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ABSTRACT
Identification of Conserved Protein Kinase CK2 and 14-3-3 Target Sites In
Neurogenic Transcriptional Regulators
Lucas Matthew Jozwick
	
  
In the decades following the identification of CK2 as the first ‘phosphotransferase’, a
great deal has been learned regarding its biological importance. In one developmental
context, CK2 regulates cell fate decisions during Drosophila neurogenesis by activating
the E(spl)M8 repressor, a terminal effector of the Notch pathway. The finding that CK2
is intimately involved in retinal cell determination propelled a search for additional
neurogenic factors regulated by CK2. Here, using bioinformatics and biochemical
assays, the transcription factors E(spl)Mγ, Extramacrochaetae, and Sine Oculis were
identified and characterized as targets of CK2. Significantly, each of these factors is
expressed at distinct time points of eye development and thereby adds to the
participation of CK2 in neurogenesis. Furthermore, E(spl)M8, -M5, and -M7
phosphorylation studies revealed that specific residues in the C-terminal domain
regulate these repressors. However, the sequence motifs present in the
aforementioned are variable and not present in all E(spl) members, raising the
possibility of divergent regulation. Interestingly, previous experiments suggested that
the cofactor 14-3-3 formed complexes with most E(spl) proteins. Bioinformatics and
genetic analyses revealed a conserved 14-3-3 interaction motif in E(spl)Mδ and its
mammalian homologs HES1 and HES4. These findings demonstrate a functional
diversification among E(spl) repressors through disparate kinases and protein cofactors.
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PREFACE
The development of metazoan organisms from a single cell is dependent upon
precisely orchestrated genetic and biochemical programs. Most important among the
processes involved in animal development are short range and long range signaling
cues. These messages are conveyed in the form of small molecules, proteins or
peptides and received through surface receptors on target cells or tissues. Remarkably,
the diversity of cells in a developing organism are brought about by the integration of a
modest collection of extracellular biochemical inputs that profoundly alter gene
expression in the target cells (Mayya et al., 2009). Therefore, the position of a cell and
the specific signals that are received by it result in diverse outcomes such as growth,
migration, differentiation, or cell death.
The Notch pathway is among the small number of communication mechanisms
involved in organismal development (Aitken, 1995; Yaffe et al., 1997; Bray, 1998;
Gridley, 2003; Voas and Rebay, 2004; Bray, 2006; Artavanis-Tsakonas and Muskavitch,
2010; Bray and Bernard, 2010). The Notch receptor responds to its ligands on adjacent
cells to mediate communication that is critical for juxtacrine signaling. Mechanistically,
Notch receptor activation elicits expression of transcriptional repressors encoded by the
Enhancer of Split Complex (E(spl)C), which affect fate specification in a cell
autonomous manner, and are terminal effectors of this pathway (Knust et al., 1987;
Preiss et al., 1988; Klambt et al., 1989; Delidakis and Artavanis-Tsakonas, 1991; Knust
et al., 1992; Schrons et al., 1992). In this system, the signal sending and receiving cells
take up divergent differentiated states, a process called ‘binary cell fate determination’.
This role in binary cell fate determination was first identified in neurogenesis. Since
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then, it has been found to operate in a remarkably similar manner in myogenesis,
oogenesis, and somitogenesis and has served as a foundation to our understanding of
mammalian Notch signaling (Louvi and Artavanis-Tsakonas, 2006). As the binary
outcomes driven by Notch signaling hinge upon the activity of the E(spl) repressors,
understanding regulation of these proteins through post-translational modifications is of
paramount importance.
The original conception of the E(spl)C was that the seven bHLH repressors
encoded by this locus were redundant and that differences in function were solely
dependent upon variation in expression pattern (Cooper et al., 2000). This idea was
drawn out of the observations, that the individual repressors were very similar in
sequence except within an unstructured stretch of amino acids near the C-terminus, and
because ectopic expression of individual E(spl) repressors led to generalized loss of
mechanosensory bristles. However, no effects on eye development were induced, an
unexpected finding because the onset of retinal neurogenesis is also under the control
of E(spl) proteins (Nagel and Preiss, 1999; Nagel et al., 1999). Therefore, this region
was concluded to be of little importance except for the invariant C-terminal WRPW motif
that is essential for recruitment of the obligate corepressor, Groucho (Paroush et al.,
1994). Later, this paradigm was challenged by a demonstration that specific
modification by protein kinase CK2 alters repressor activity (Trott et al., 2001b). This
highlights the yet to be illuminated diversity of regulatory consequences mediated by the
C-terminal sequences.
Years of research have demonstrated that the Notch pathway is critical for proper
development. However, the regulatory features of the seven E(spl) repressors in the
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diversification of Notch activity remain a poorly understood mechanism. Furthermore,
the role of protein kinase CK2 in metazoan development and in the regulation of
transcription factors involved in neurogenesis is incomplete. Therefore, this and
subsequent chapters address structural features that mediate regulation of Enhancer of
Split Complex repressors and the role of CK2 in regulating disparate stages of neuronal
determination.
Biochemistry of Protein Kinase CK2
The serine/threonine protein kinase CK2 was originally identified in rat liver
extracts as an enzyme that catalyzes the addition of phosphates to the protein casein
(Burnett and Kennedy, 1954). CK2 is ubiquitously expressed in eukaryotic cells and
targets hundreds of cellular proteins (reviewed in (Meggio and Pinna, 2003)). In all
organisms studied to date, this protein kinase is a hetero-tetramer (Fig. 1), a composite
of two α-subunits, which bind to a dimer of β-subunits (Glover et al., 1983; Dahmus et
al., 1984; Padmanabha and Glover, 1987; Bidwai et al., 1994; Niefind et al., 2001). The
α-subunit harbors catalytic phosphotransferase activity, and it can utilize either ATP or
GTP as a substrate (Hathaway and Traugh, 1979; Glover et al., 1983). The activity of
CK2α is stimulated by the regulatory β-subunit, which modulates substrate recognition
and may provide stability to the αββα holoenzyme (HoloE, (Cochet and Chambaz,
1983)). Antibodies specific for the mammalian CK2 demonstrate cross reactivity with
homologous proteins from Drosophila (Dahmus et al., 1984), the first line of evidence
for strong conservation. In parallel, the CK2α subunit from Drosophila, humans, and
nematodes can functionally substitute for the yeast kinase and temperature sensitive
phenotypes associated with the α-subunit are suppressed by concomitant expression of
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human CK2β (Padmanabha et al., 1990; Bidwai et al., 1992; Dotan et al., 2001). These
observations, along with extensive sequence identity among homologs, reveal that the
subunits are evolutionarily conserved in both structure and function (Glover et al.,
1994).
CK2 is distinguished from other protein kinases because it does not respond to
second messengers and preferentially targets acidic substrates. Regarding the latter,
the consensus sequence for CK2 has been identified as S/T-D/E-x-D/E (Fig. 1) where
‘x’ is neither of the basic amino acids lysine or arginine (Kuenzel and Krebs, 1985;
Kuenzel et al., 1987). Additional acidic residues in proximity to the target
serine/threonine further enhance CK2 activity toward target proteins. Given the
hydrophilic nature of these acidic microdomains, it is likely that the region is solvent and
surface accessible, which makes site identification more facile. Moreover, processive
phosphorylation by CK2 is potentiated because phosphorylated residues can replace
the requirement for acidic residues in the consensus. Therefore, if a CK2 consensus
(for example SSSESE) is phosphorylated (SSSEpSE), it generates a series of
hierarchical sites (SSSEpSE) (Fig. 1) that expands the acidity and charge of the region
dramatically. This hierarchical phosphorylation can also involve other protein kinases,
such as the coordinated regulation of protein phosphatase by GSK3 and CK2 (DePaoliRoach, 1984; Roach, 1991). One of the most dramatic examples is Nopp140, a nuclear
cytoplasmic shuttle, which is phosphorylated in a hierarchical manner by CK2 at 82
sites (Meier and Blobel, 1992).
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Biology of CK2
In the years following the description of protein kinase CK2, a number of
substrates have been identified. In a review by Meggio and Pinna (2003) some 307
targets are compiled and subdivided into groups. Examples of classified targets range
from transcription factors and signaling molecules to metabolic enzymes and viral
proteins (Meggio and Pinna, 2003). While the list of substrates is lengthy and diverse,
perhaps the most important physiological roles for CK2 lie in cell cycle control, signaling
and transcription factor regulation (Glover, 1998).
The role of CK2 in the cell cycle was first revealed by studies in the budding
yeast Saccharomyces cerevisiae. In these cells, a complete loss of the two CK2α
subunits (CKA1 and CKA2) leads to cell death (Padmanabha et al., 1990), while a
depletion of kinase levels results in cell cycle arrest as budded or unbudded cells as
well as an elongated phenotype (Hanna et al., 1995; Rethinaswamy et al., 1998).
These results have been recapitulated in the fission yeast, Schizosaccharomyces
pombe (Snell and Nurse, 1994). Interestingly, loss of CK2β results in no overt
phenotype, but combinatorial deletion of α and β genes exhibits a slow growth
phenotype, suggesting that CK2 is required for cell proliferation. Studies in Drosophila
have revealed that CK2 is required for embryogenesis, cell fate specification (Jaffe et
al., 1997; Karandikar et al., 2004; Bose et al., 2006), and the circadian clock (Lin et al.,
2002; Akten et al., 2003). These findings correlate with mammalian model systems
where CK2 is required for cell proliferation in the mouse (Buchou et al., 2003;
Dominguez et al., 2011), survival in human cancer cell lines (Faust et al., 2000) and
proper formation of developing structures during mouse embryogenesis (Lou et al.,
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2008). However, knockouts of CK2β in the mouse model result in loss of proliferation,
increased cell death, and embryonic lethality (Buchou et al., 2003).
In congruence with the observed phenotypes of cell survival and proliferation is
CK2’s targeting of tumor suppressors. The phosphatase PTEN, which influences cell
migration, growth, and survival, is C-terminally phosphorylated by CK2, resulting in
proteasomal degradation (Torres and Pulido, 2001). CK2 also regulates the levels of
PML a key regulator of growth, apoptosis and cell division (Scaglioni et al., 2006). As a
final example, DNA binding of p53 is promoted by CK2 phosphorylation (Blaydes and
Hupp, 1998), though there is some disagreement regarding the phosphorylating kinase
(Cox and Meek, 2010; Meek and Cox, 2011). These mechanisms are of note because
of their significance in the regulation cellular events, but CK2 is also involved at multiple
levels in signaling pathways, and these pathways participate in multiple biological
outcomes.
As development is a synchronization of biochemical and genetic events, the role
CK2 plays in signaling systems is of great importance. As an example, the kinase
participates in the Wnt signaling pathway by phosphorylating β-catenin thereby
potentiating its transcriptional activity through stabilization (Song et al., 2003);
additionally, CK2 targeting of PKB/AKT maximizes that kinases activity with respect to
β-catenin leading to upregulation of transcriptional output (Ponce et al., 2011). CK2 is
also a critical component of the JAK/STAT pathway, where targeting of JAK2 prevents
autophosphorylation and signal transduction (Zheng et al., 2011). Another role for CK2,
and of particular relevance in this review and discussed in detail elsewhere, is in the
Notch signaling pathway. One of the primary effectors of Notch signal transduction,
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E(spl)M8 in Drosophila or HES6 in humans, harbors a CK2 site that is critical for its
repressor function (Gratton et al., 2003; Karandikar et al., 2004). Furthermore, CK2 also
targets TLE1, the obligate corepressor of fly E(spl) and homologous mammalian HES
proteins, thereby allowing its corepressor function to be activated during neurogenesis
(Nuthall et al., 2004).
In addition to serving primary roles in various stages of signal transduction, CK2
also regulates transcription factors involved in the early stages of body plan
establishment. For example, modification of the HOX transcription factor Antennapedia
reduces its activity and inhibits cooperative DNA binding with the homeodomain
Extradenticle (Jaffe et al., 1997). As an additional example, CK2 allows appendage
formation by inactivating Ultrabithorax through phosphorylation of residues C-terminal to
the homeodomain (Taghli-Lamallem et al., 2008).
Other aspects of CK2 regulation include modulation of cell structure and
morphology as mediated by actin filament and microtubule assembly (Canton and
Litchfield, 2006), phosphorylation of core (basal) components during gene transcription
(Bierhoff et al., 2008), and protein folding mediated by Hsp90 (Miyata, 2009). It is the
intimate association of CK2 with core cellular functions during gene expression, protein
folding, growth, proliferation, survival, signaling, and development that make it an
interesting topic of research. Also, many of the pathways in which CK2 is involved
contribute to genetic disorders and neoplasia. These facts demonstrate that an
understanding of CK2 and the consequences of its targeted phosphorylation are of key
importance in understanding a variety of biological occurrences and disease states.
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Signaling through the Notch receptor
The ‘notched’ wing phenotype first observed by John S. Dexter led to the
description of X-linked mutants of the Notch gene by T. H. Morgan (Morgan, 1916).
Though the inheritance pattern of the Notch allele was clearly defined therein, a full
investigation into the functional nature of the pathway would not be undertaken for
nearly a quarter century. Studies by David Poulson demonstrated a lack of
segmentation and improper germ layer formation in Notch mutants (Poulson, 1937).
Furthermore, he suggested that there was an interdependence of neural hyperplasia
and epidermal hypoplasia in Notch deficient organisms (Poulson, 1940). This was the
first indication that Notch was involved in the selective determination between the neural
and epidermal fates.
Owing to its role in binary cell fate determination, it comes as no surprise that the
Notch pathway has ancient origins and is highly conserved in vertebrates and
invertebrates. Homologs of Notch have been identified in Caenorhabditis elegans,
Xenopus laevis, and four distinct homologs exist in mammals (Greenwald et al., 1983;
Coffman et al., 1990; Uyttendaele et al., 1996). Additionally, extensive study of the
Notch pathway has revealed many of its roles throughout development and in the adult
organism. These include boundary formation, proliferation, apoptosis and stem cell
maintenance. Specific outcomes mediated by Notch are always achieved through
juxtacrine signaling cues that require close apposition of the signaling and responding
cells, although this can occur across several cells through filopodia (Cohen et al., 2010;
Milan and Cohen, 2010). Since Poulson’s pioneering work, binary cell fate decisions
influenced by Notch have been studied in astonishing detail during the patterning of the
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Drosophila retina and the mechano-sensory bristles. This process, termed lateral
inhibition (Simpson et al., 1999; Simpson and Marcellini, 2006), occurs during
neurogenesis to properly pattern neurons by progressively restricting neuronal-potential
from a group of equipotent cells (reviewed in (Greenwald and Rubin, 1992). While
lateral inhibition is the canonically cited function of Notch, it can induce changes in cell
fates among independent cell types and it is also involved in asymmetric cell divisions
(reviewed in (Lai, 2004)). Examples of these signaling strategies in Drosophila include
boundary formation in the wing and cell divisions of neuroblasts in the developing
bristle, respectively.
As described, research has clearly defined the Notch signaling pathway as one
that influences diverse signaling outcomes in a variety of contexts. Its misregulation
underlies a number of congenital and adult disease states in humans. Examples
include heart valve defects (Garside et al., 2013), Allagile syndrome characterized by
organ and skeletal abnormalities (McCright et al., 2002), the hematopoietic malignancy
multiple myeloma (Colombo et al., 2013), the skeletal abnormality spondylocostal
dysostosis (Sparrow et al., 2010), and neurodegenerative diseases such as Batten
syndrome (Tuxworth et al., 2009). Additionally, the Notch pathway is of clinical interest
for developing effective tissue transplantation strategies that mitigate host rejection
(Tran et al., 2013). Because of its association with congenital defects, cancer etiology
and clinical advancement, Notch is a prime candidate for continued investigation.
Notch Signaling and Activation of Enhancer of Split Complex Genes
Activation of the Notch signaling pathway is stimulated by the presence of
transmembrane ligands on adjacent cells. In Drosophila these ligands are called Δ (Dl)
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and Serrate (Ser) (Rebay et al., 1991). Receptor-ligand interaction results in exposure
of an ADAM family metalloproteinase site on the extracellular side of the membrane,
which is otherwise inaccessible (Mumm and Kopan, 2000) (Fig. 2). Subsequently, the
exposed site is cleaved by Kuzbanian (Pan and Rubin, 1997). Ligand binding and
proteolytic cleavage of the extracellular target site represents the critical regulated steps
for signal transduction. However, further proteolytic cleavage by the presenilin γsecretase at sites within the transmembrane region is required to release the Notch
intracellular (Nicd) domain and allow its translocation to the nucleus where it affects gene
transcription (Schroeter et al., 1998; Okochi et al., 2002) (Fig. 2).
In the nucleus, the regulatory regions of the Enhancer of Split Complex (E(spl)C)
genes are held in an inactive state (repressed) by Suppressor of Hairless (Su(H)) and a
co-repressor complex comprised of Hairless (H), C-terminal binding protein (CtBP), and
Groucho (Gro) (Bailey and Posakony, 1995; Barolo et al., 2002). Following the
proteolytic processing of Notch, the Nicd enters the nucleus mediated by its nuclear
localization sequence (NLS) (Lieber et al., 1993). There, it transforms Su(H) into an
activation complex by recruiting Mastermind (Mam) , leading to transcriptional output
from the previously repressed genes, particularly E(spl)C (Petcherski and Kimble, 2000)
(Fig. 2).
The Enhancer of Split Complex
The etymology of this complex is derived from an enhancement of the split (spl)
allele of the Notch receptor by the mutant ‘Enhancer of split Dominant’ (E(spl)D or m8*),
which results in near complete ablation of neural cell specification in the Drosophila eye
(Welshons, 1965). Later, eight related transcriptional units were identified in the
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genomic locus mapping near E(spl)D on the 3rd chromosome (Fig. 3). Seven of these
encode highly conserved basic-helix-loop-helix (bHLH) transcription factors (E(spl)-m3,
-m5, -m7, m8, -mβ, -mδ, -mγ) and the non-bHLH co-repressor groucho (gro) (Delidakis
et al., 1991; Knust et al., 1992).
The seven E(spl) proteins share well conserved domains each with specific
biochemical functions (Fig. 3). Nearest the N-terminus, the basic and HLH confer DNA
binding and the capacity for dimerization among E(spl) members, respectively. The
bHLH is followed by the Orange domain, another HLH necessary for complex formation
with target proteins (see below). Finally, the extreme C-terminus harbors the invariant
WRPW motif, which is required for interaction with Gro. Interestingly, while differences
in primary sequence exist in each of the aforementioned domains (except WRPW),
there is a region of hypervariablility that occurs in the intervening region between the
end of the Orange domain and the WRPW motif. This region is called the C-terminal
domain (CtD).
Early assessment of the E(spl)C suggested that the encoded proteins were
functionally redundant. This was based primarily on the observation that only extensive
deletions of the complex generated neurogenic phenotypes, while point mutations alone
were insufficient (Preiss et al., 1988; Ziemer et al., 1988). The structural similarities
among the proteins have unfortunately led to broadly held conceptual bias that E(spl)
repressors are redundant for neural repression. However, this argument was
substantially weakened by the conservation of particular motifs within the CtDs of
E(spl)-M5, M7 and M8 (Maier et al., 1993). Moreover, molecular synteny of the locus
between Drosophila melanogaster and Drosophila hydei, two species separated by
	
  

18

some 60 million years of evolution, suggests that there are important functions mediated
by the individual genes (Maier et al., 1993), and that the notion of redundancy is an
erroneous oversimplification.
Later explanations of apparent redundant activity assumed that differential
patterns of expression were dependent upon spatially restricted factors and that this
served as the sole regulatory mechanism controlling E(spl) function (Cooper et al.,
2000). This idea is supported by studies that find cell specific expression to be the
product of the number and orientation of Suppressor of Hairless (Su(H)) binding sites
(Cave et al., 2005). Furthermore, there is significant variability in Su(H) binding site
occupancy among E(spl) enhancers (Krejci and Bray, 2007) and levels of transcriptional
responses vary amongst E(spl) genes following activation of Notch (Housden et al.,
2013). However, this is an apparent oversimplification of the regulatory mechanisms
that impinge upon these transcription factors.
Research over the past decade has revealed post-translational mechanisms that
alter the activity of E(spl) proteins. Specifically, E(spl)-M5, -M7 and -M8 are
phosphorylated in a shared sequence motif of the CtD by protein kinase CK2 (Trott et
al., 2001a). This modification has since been shown to be of significant regulatory
consequence to the repressive functions intrinsic to E(spl) proteins. In particular, E(spl)M8 has served as the target of research that has revealed the necessity of posttranslational regulation in neural repression.
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Repression by Enhancer of Split
Because the DNA binding motifs of E(spl) proteins are conserved, it was initially
proposed that enhancer binding was the primary means of transcriptional repression.
This proposal was based on the observations that transcriptional output from reporters
is dramatically reduced by E(spl)M7 (Van Doren et al., 1994), and that chimeras of
E(spl)M7 with heterologous activation domains enhanced transcription in a DNA binding
dependent manner (Jimenez and Ish-Horowicz, 1997). Additionally, the N-box binding
consensus of E(spl) proteins is conserved in the ASC enhancer whose activity is
decreased by the presence of E(spl)M5 and E(spl)M8 (Oellers et al., 1994) and loss of
DNA binding attenuates the phenotype associated with the dominant E(spl)D allele
(Tietze et al., 1992). Contradictory studies indicated that neural suppression in the
bristle was independent of the bHLH but depended only on a subset of helices within
the repressor (Nakao and Campos-Ortega, 1996; Giebel and Campos-Ortega, 1997).
The lack of bHLH requirement combined with the interaction affinity between proneural
activators and E(spl) proteins led to the ‘molecular tether model’. This model postulates
that direct protein-protein complex formation between activators and repressors at the
enhancer results in antagonism. Interaction is generally thought to be mediated by the
Orange domain of all E(spl) repressors (Dawson et al., 1995). However, the means and
the regulation of these seemingly simple binary interactions have proven to be more
complex.
During bristle development, interaction of E(spl) proteins with Achaetae (Ac) and
Scute (Sc) occurs through the bHLH domains (Gigliani et al., 1996). However, during
neurogenesis in the eye, the specific mechanism lacked clarity. It was apparent that
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E(spl) antagonized Atonal (Ato), the eye specific proneural activator, due to the severely
reduced eye of the E(spl)D mutant (Nagel et al., 1999). Elucidation of the relevant
mechanism was initiated with the finding that CK2 targets a conserved consensus motif
in the CtD of E(spl)M5, M7 and M8 (Trott et al., 2001a). In vivo experiments
demonstrated that phosphomimicry of CK2 sites potentiates interaction with Ato and
that levels of interaction are similar to the truncated form of E(spl)M8*, which lacks the
CtD (Karandikar et al., 2004). As E(spl)M8, outside of a phosphorylated state, is unable
to interact with Ato, an autoinhibitory model was proposed (Karandikar et al., 2004).
Here, the unstructured CtD blocks the protein surface that would engage with Ato.
Upon phosphorylation of E(spl)M8 by CK2, the autoinhibition is released and complex
formation is allowed to occur, thereby inhibiting ato autoregulation. The structural
model is supported by reversal of E(spl)M8 hypermorphic phenotypes by
overexpression of the CtD segment (Kahali et al., 2010).
Thus, it appears that the CtD regulates formation of the E(spl)M8/Ato complex.
Interestingly, the CK2 target site lies in a serine rich region, raising the prospect of
regulation through additional phosphorylation. Indeed, a number of phosphorylation
consensus motifs exist in this region for other protein kinases, including MAPK (P-x-SP), CK1 (pS/T-x-x-S) and GSK3 (S/T-x-x-x-pS/T). Interestingly, a secondary
phosphorylation mechanism has been described for the human and mouse HES6
homolog with respect to CK2 and MAPK (Belanger-Jasmin et al., 2007). This feature
has garnered the region the description as a phosphorylation domain (P-domain).
These findings can be extrapolated to develop a deeper understanding of E(spl)
repressor function and regulation. The conservation of the P-domain among Drosophila
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orthologs and its presence in paralogs suggests that this feature is of regulatory
significance. Furthermore, the lack of this particular motif and variations in other
homologs indicates that the large family of bHLH-Orange proteins that regulate diverse
developmental programs employ distinct means to attain transcriptional repression.
Therefore, divergence in post-translational regulation implies disparate function, which
is specialized to the signaling systems active in a particular context. These ideas are a
central to the thesis.
Making a Drosophila Eye
The Drosophila eye is composed of 750-800 identical facets called ommatidia
that are formed into a finely patterned hexagonal lattice (Fig. 4C). Each ommatidium is
stereotypically composed of eight photoreceptors, called R1-8, four cone cells and
pigment cells. Patterning of each ommatidium is dependent upon highly regulated
selection of the ‘founding R8’; so named because it recruits all other cells into each
ommatidium. As any perturbation of retinal patterning is easily observable, the
Drosophila eye has been used extensively to understand tissue development as it
pertains to cell signaling and fate specification (Roignant and Treisman, 2009).
Body regions of the adult organism derive from individual compartments that
arise during development called ‘imaginal discs’. In the early embryo, approximately 20
cells are designated to form an epithelial monolayer of pluripotent cells of the ‘eye
imaginal disc’ (Fig. 4A). Expression of ‘retinal determination network’ (RDN, Fig. 5) Pax
genes such as twin of eyeless (toy), eyeless (ey), eyegone (eyg), and twin of eyegone
(toe) marks the onset of retinal neurogenesis and is required for organ formation.
These Pax genes then drive expression of other network members such as sine oculis
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(so) and eyes absent (eya) (Hirata et al.). SO and Eya form a bipartite transcription
factor that regulates early steps in eye formation including morphogenetic furrow
formation and movement (Pauli et al., 2005) and expression of the retinal neuron
specific proneural gene ato, described below (Zhang et al., 2006) (Jarman et al., 1994;
Jarman et al., 1995). Earlier studies implicated phosphorylation dependent regulation of
Eya, but this appears to be an artifact ((Jusiak et al., 2012). In contrast, regulation of
SO by post-translational modification has not been described and is the subject of
studies in Chapter 2 (see below).
During the first and second larval stages, the eye imaginal disc grows in size, but
cell fate specification (commitment and differentiation) does not commence until the
third larval stage. The beginnings of neural specification in this tissue require the
expression of ato, a bHLH transcriptional activator (Jarman et al., 1994). Initially,
groups of equipotent cells, the ‘proneural clusters’ (PNC), have comparable ato activity.
However, only a single cell from each PNC is allowed to maintain sufficient levels of ato
expression to become an ‘R8 founding neuron’ (R8). Without ato, R8s do not form and
the eye is lost, whereas excess specification of R8s leads to a ‘rough’ eye phenotype
(White and Jarman, 2000). R8s are selected through a process in which Notch is
critically involved (Artavanis-Tsakonas et al., 1999). During specification, Notch
activities are biphasic and separated in space and time about a wave of differentiation
that sweeps toward the anterior of the developing primordia, the morphogenetic furrow
(Fig. 4A and B).
The morphogenetic furrow (MF) is marked by an apico-basal constriction (Ready
et al., 1976; Cagan and Ready, 1989; Wolff and Ready, 1991a; Wolff and Ready,
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1991b). Cells anterior to the MF remain unspecified and undifferentiated (Fig. 4A);
however, as the MF passes across the disc, cells alter their expression patterns and
execute genetic programs that drive specification and differentiation (Ready et al.,
1976). Because there are distinct transitional phases during R8 specification in the MF,
it is subdivided into four distinct stages of progressive refinement.
The secreted factor Hedgehog (Hh) is expressed in differentiating photoreceptors
at the posterior margin of the MF (Heberlein et al., 1995). It is critical for progression of
the MF as one of its targets, decapentaplegic (Dpp), is a long range signaling factor that
drives expression of ato and its negative regulators hairy (h) and extramacrochaetae
(emc) (Brown et al., 1995). Ultimately, the cells anterior to the MF will undergo
differentiation and themselves express hh, the result is MF wave-like movement.
Additionally, Hh along with Notch, stimulates expression of ato in a band of cells
immediately anterior to the MF, while Notch down regulates the repressors h and emc
(Baonza and Freeman, 2001). Thus, regulation of ato is restricted to areas anterior to
the MF, imparting directionality to the furrow. Overall, this is stage 1 of the MF (Fig. 4)
and is commonly referred to as ‘proneural enhancement’ due to the broad and uniform
augmentation of the proneural gene activity. This regulatory mechanism is required to
establish neuronal competency and drives the formation of the PNCs from which R8s
are derived. Importantly, in this context Notch function is independent of Su(H) or the
bHLH repressors of E(spl)C (Baker et al., 1996). This contrasts the second role of
Notch during lateral inhibition.
Several cells compose each PNC. It is imperative that only a single cell from
each cluster be designated the founding R8 so that the patterning of the tissue is
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maintained (Fig. 4). This is achieved through lateral inhibition and is mediated by Notch
at stage 2/3 of the MF (Muskavitch, 1994). Initially, a single cell establishes a higher
level of ato activity. This presumptive-R8 initiates lateral inhibition because it expresses
the Notch ligand, Δ, at higher levels than other cells of the PNC (Kunisch et al., 1994).
As a result, Notch activity is higher in the non-R8s as is the expression of the E(spl)C
antagonists of ato. Ultimately, the expression of the proneural Ato protein is
extinguished in all other cells except the R8.
After R8s are specified, the secondary cells are recruited sequentially, during and
after stage 4 (Fig. 4), to the final sensory unit. The ordered recruitment orchestrated by
the R8 involves specification of R2/R5, R3/R4, R1/R6, R7, cone cells and the pigment
cells. This process of secondary cell acquisition represents an inductive process
mediated by the Notch receptor (Roignant and Treisman, 2009).
Retinal Determination Factor Sine Oculis
The identification of the SIX-family of transcription factors originated with the
description of sine oculis (so) in Drosophila (Kumar, 2009a; Kumar, 2009b). Consistent
with its inclusion in the retinal determination network (Fig. 5), compromised so function
leads to abnormalities in all facets of the visual system including absence of the eye in
the adult organism (Cheyette et al., 1994; Serikaku and O'Tousa, 1994). Later, the SIXfamily grew when two additional paralogs of so were revealed. These genes, termed
optix and DSix-4, are involved in other developmental programs. Further genome
comparisons indicated that all of these genes are conserved in vertebrates, where
duplication events resulted in expansion of gene number. Here, I primarily consider so
and its vertebrate homolog six1.
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Structurally, SIX proteins are composed of two domains: a homeodomain (HD),
classically defined in protein-DNA interactions, and the namesake SIX domain, involved
in the formation of protein complexes (Kumar, 2009a; Kumar, 2009b). The most well
studied protein interaction for SO/SIX1 is its engagement with the transcriptional
activator and tyrosine phosphatase, Eya . It is the combination of the DNA binding
ability of SO and the activation domain of Eya that allows this bipartite transcription
factor to regulate gene expression. The importance of this complex is apparent as any
disruption of the complex results in severe developmental defects (reviewed in (Xu,
2013)) and combined overabundance is associated with neoplasticity (reviewed in
(Christensen et al., 2008)).
While the protein interaction between SO and Eya is well established, there is
disagreement in the literature regarding the mechanism by which SO binds DNA. As a
first indication, molecular dissection of SO suggested that a region of the protein
corresponding to the HD was stable and could reliably complex with DNA (Hazbun et
al., 1997). These results are contrasted by human SIX2, a close paralog of SIX1, where
the HD does not interact with DNA; however, full-length SIX2 does bind DNA (Hu et al.,
2008). This suggests other parts of the protein, perhaps the SIX domain, endow or
augment DNA interaction. This idea is buttressed by the observation that spontaneous
mutations in the SIX domain of SIX1 abrogate DNA binding and manifest as brachiooto-renal (Huang et al., 2009) syndrome, a developmental disorder marked by hearing
and kidney problems (Patrick et al., 2009). Furthermore, recent structural determination
of the human SIX1-EYA complex reveals that the α-6 helix of the SIX domain is
available for interaction while in complex with EYA (Patrick et al., 2013).
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This problem of DNA binding by SO/SIX1 is compounded by the finding that
phosphorylation by CK2 results in a decrease of SIX1 DNA binding affinity (Ford et al.,
2000). A clarification of the mechanism of DNA interaction for SO/SIX1 and its
regulation by CK2 is critical to our understanding of the molecular functioning of a
conserved transcriptional modulator.
Making the Macrochaetae
The macrochaetae of Drosophila are mechanosensors, a component of the
peripheral nervous system (Ghysen and Richelle, 1979; Simpson, 1990; Garrell and
Campuzano, 1991; Gomez-Skarmeta et al., 2003). Bristles of the notum maintain
bilateral stereotyped patterns in the dorsocentral and dorsolateral regions and on the
shield shaped scutellum of the posterior thorax. Each bristle is composed of four
specialized cells: neuron, sheath, shaft and socket (Fig. 6). These cells arise through
asymmetric division of a single ‘sensory organ precursor’ (SOP), whose specification
(like the R8 photoreceptor, see above) is Notch dependent. The onset of the bristle
development is dependent upon expression of proneural activators derived from the
Achaetae-Scute Complex (Romani et al., 1987; Guindon et al., 2010). Unlike ato,
expression of the ASC genes does not rely on Notch, but reflects the influence of prepattern factors (Calleja et al., 2002). However, the SOP is selected through lateral
inhibition from a group of cells composing the PNC in a manner akin to the R8
photoreceptor (Simpson, 1990) (Fig. 6).
As is typical of lateral inhibition, one cell gains an advantage over other cells of a
PNC with respect to ASC expressivity. This cell initiates Notch mediated lateral
inhibition and a single cell is established as the SOP (Fig. 6), as ASC gene activity is
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extinguished in the non-SOP cells. The SOP cell yields the pI neuroblast, which
undergoes sequential asymmetric divisions. First the pI divides into the pIIa and pIIb
cells. The former divides and differentiates into the shaft and socket cells while the
latter divides into the glial and pIIIb cells. Finally, the pIIIb cell goes on to form the
sheath and neuron. This series of divisions is highly dependent upon proper signaling
through the Notch pathway and E(spl) (Schweisguth et al., 1996).
The role of Notch in bristle development is well established through a number of
loss of function phenotypes. An absence of Notch function during lateral inhibition
results in juxtaposed supernumerary bristles, i.e. little spacing between them. This is
the result of excess SOP specification. Conversely, over activation of Notch or the
E(spl) repressors ablate bristle formation as cells of the PNC lose the potential to
become the SOP. Loss of bristle phenotypes can also be due to a later (post-SOP) loss
of Notch activity, as improper formation of pIIb cells prevents pIIa from forming the
external shaft cell. Furthermore, a loss of Notch function during asymmetric cell
divisions results in abnormal shaft formations. For example, split bristles are an
aberration wherein the pIIa cellular progeny both differentiate into shaft cells. Thus, the
bristle lineage serves as a model for reiterated Notch functions during specification and
asymmetric division that are distinct from the eye.
Extramacrochaetae regulates bHLH activity
A genetic screen in Drosophila by Botas et al. in 1982 identified the
extramacrochaetae (emc) mutation as a dominant modifier of multicopy expression of
the proneural activators encoded by ASC (Botas et al., 1982). Further analysis of the
gene revealed that loss of emc elicited extra bristles in otherwise wild type flies and
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concomitant loss of ASC expression ameliorated those effects (Delprado and
Garciabellido, 1984) suggesting a close association between gene products. Dissection
of the encoded protein indicated that EMC (an HLH protein) lacks a basic domain that is
required for interaction with DNA (Ellis et al., 1990; Garrell and Modolell, 1990).
Subsequent analysis revealed that EMC dimerizes with ASC bHLH activators, and
thereby inhibits transcription of proneural target genes (Van Doren et al., 1991).
The sequestration mechanism used by Emc is employed iteratively during
development. In Drosophila, for example, Emc regulates sex determination (YoungerShepherd et al., 1992), antagonism of neuronal differentiation and patterning in the
bristle (Botas et al., 1982), timing of furrow movement and R-cell specification in the eye
(Brown et al., 1995; Bhattacharya and Baker, 2009; Spratford and Kumar, 2013), cell
proliferation and vein formation in the wing (Baonza and Garcia-Bellido, 1999), and
Malpighian tubule and trachea formation in the digestive tract (Cubas et al., 1994).
Studies of ‘inhibitors of DNA binding’ ID1-4, the murine homologs of Emc,
uncovered striking similarities in the function and mechanism of these proteins.
Specifically, loss of Id1 and Id3 leads to premature neuronal differentiation in the
developing embryo (Lyden et al., 1999). Additionally, Id proteins are involved in
angiogenesis (Lyden et al., 1999), which requires the formation of tubular structures
similar to that of the Malpighian tubules and trachea. Also, owing to its role in
preventing differentiation, overexpression of Id proteins is commonplace in a number of
tumor models where they prevent differentiation and promote cell proliferation.
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Of interest with respect to this thesis is the apparent reliance of the Notch
signaling pathway on Emc. During secondary recruitment by the R8, Emc acts in an
epistatic cell autonomous manner to Notch in the R7 and cone cells; furthermore, Emc
is required for proper expression of E(spl)C bHLH repressors (Bhattacharya and Baker,
2009). The striking similarities in the roles of Emc/Id during development, signaling and
cancer underscore the importance of understanding in better detail this mechanism of
action. In this regard, our knowledge of post-translational regulation of EMC/ID
remained unexplored (see Ch. 2). Therefore, understanding this aspect of protein
modulation could provide insight into how cell fates are determined and differentiation is
regulated.
The 14-3-3 Family of Proteins
A 1967 survey of bovine brain tissue resulted in the identification of a new family
of proteins (Moore et al., 1967). These proteins, dubbed 14-3-3s, derive their name
from a combination of their elution position in DEAE cellulose chromatography and
starch gel-electrophoresis. At a mass of 30kDa, these acidic proteins are expressed in
all eukaryotic cell types. The Drosophila genome contains two genes (14-3-3ζ and ε)
while the human genome encodes seven distinct isoforms (14-3-3β, γ, ε, η, ω, τ and ζ).
Proteins of this family typically function as dimers, with some isoforms preferentially
forming homodimers, while others function as heterodimers.
14-3-3s were the first group to be described as phosphoprotein binding proteins
(Fu et al., 2000; Dougherty and Morrison, 2004; Aitken, 2006). Specifically, a largescale screen identified two motifs that drive protein-protein interaction: mode-1, R-S-xpS/pT-x-P, and mode-2, R-x-F/Y-x-pS/pT-x-P, where ‘x’ is any amino acid and ‘pS/pT’
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indicates a phosphorylated serine or threonine residue (Yaffe, 2002; Wilker et al., 2005).
While these phosphospecifc motifs are considered to be optimal, a number of verified
binding sites diverge from the strict consensus and others bear no similarity. For
example, the 14-3-3 interaction motif of the ADP-ribosyltransferase S of Pseudomonas
is identified as D-A-L-D-L (Henriksson et al., 2002) and the binding site of human p53 is
K-G-Q-S-T-pS-R-G (Waterman et al., 1998). Interestingly, many of the identified sites
(~75%-90%) are located in or near regions predicted to be structurally disordered
(Bustos and Iglesias, 2006). The emerging view is that regions of ‘disorder’ are often
the sites for regulatory post-translational modification, which serve to impose structural
stability. Regardless of the sequence motif that causes complex formation, 14-3-3
proteins regulate hundreds of proteins involved in signal transduction (Tzivion et al.,
1998), transcriptional regulation (Ren et al., 2010; Yu et al., 2013), chromatin structure
(Healy et al., 2011), and vesicle trafficking (Li et al., 2012), among others.
Functional modulation by 14-3-3s can occur through a variety of mechanisms
(reviewed in (Darling et al., 2005)) (Fig. 7). The molecular anvil hypothesis (Yaffe,
2002) describes a mechanism in which binding the highly structured 14-3-3 acts as a
foundation for conformational change or stabilization. Also, binding by 14-3-3 can
prevent phosphatase access and thereby sterically blocking dephosphorylation and
maintaining an altered functional state. Interaction between two proteins can be
prevented if a binding interface is occluded or 14-3-3 might serve as a molecular
scaffold and facilitate binding if both partners contain a target site. Finally, interaction
with 14-3-3 can drive compartmental sequestration or trafficking by serving as a
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molecular escort. These mechanisms are implemented in a number of contexts to
influence a variety of cellular events.
Cellular processes regulated by 14-3-3s include signal transduction, transcription
factor localization, cell cycle progression and apoptosis. Examples include strict
regulation of Raf (Fu et al., 1994) by maintaining an active conformation of the kinase
(Tzivion et al., 1998), regulation of the cell cycle phosphatases Cdc25B/C (Peng et al.,
1997; Forrest and Gabrielli, 2001), cytoplasmic restriction of the transcription factor
Yorkie (Ren et al., 2010) and sequestration of the apoptotic promoting protein BAD (Zha
et al., 1996). The Raf and Yorkie examples of 14-3-3 functions have been elucidated in
the Drosophila model system, particularly the eye. This suggests that 14-3-3s have
roles in regulating pathways important for neurogenesis and cell fate specification.
Though expression of 14-3-3 is ubiquitous, its expression is maximal posterior to
the MF where photoreceptor differentiation occurs (Kockel et al., 1997). These are the
regions (discussed above and Fig. 4) where Notch is involved in lateral inhibition and
secondary photoreceptor induction. Given a concomitant increase in 14-3-3 and
E(spl)C expression, there may be a significant regulatory consequence underlying this
coexpression. Perhaps these two proteins are involved in a developmental context
whereby multiple E(spl) repressors are regulated through interaction with 14-3-3s.
GSK3 and Neuronal Development
Glycogen-Synthase-Kinase-3 (GSK3) is a serine/threonine kinase originally
identified as a key regulator of glucose metabolism (Woodgett and Cohen, 1984). Since
this initial report, new roles for the kinase have been uncovered in clinical contexts,

	
  

32

circadian rhythm, as well as development. Relevant developmental roles for the kinase
include neurogenesis, neuronal migration and polarization, and axon growth and
guidance (Hur and Zhou, 2010).
GSK3 is specialized in its substrate recognition in that it preferentially modifies
proteins that have already been phosphorylated. Typically, the phosphorylated residue
is four or five positions C-terminal to the candidate serine or threonine. Thus, the
general consensus has been described as S/T-x-x-x-pS/pT where ‘x’ is any residue and
‘pS/pT’ represents a phosphorylated serine/threonine. This ‘priming’ dramatically
increases affinity for a particular substrate and serves to regulate GSK3 targeting.
However, priming is an enigmatic phenomenon because it is not necessary for some
substrates, or relevant sites may be located distal the target residue (reviewed in
(Sutherland, 2011)).
In addition to its unique target preferences, GSK3 is distinguished by its high
basal activity in resting cells. Stimulation of upstream signaling components results in
decreased kinase activity, which is counter to the norm. For example, GSK3 is
responsive to growth factors through receptor tyrosine kinase (RTK) signaling.
Activation of the phosphatidylinositol-3-phosphate kinase pathway (PI3K) leads to an
inhibitory phosphorylation of GSK3 by Akt (Cross et al., 1995). Additionally, the Wnt
signaling pathway leads to GSK3 inactivation by forcing it to dissociate from its
substrate β-catenin. Ultimately, the kinase is recruited to the membrane where it is
sequestered by complex formation with the Wnt coreceptor LRP5/6 (Piao et al., 2008).
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Studies in mammalian systems have revealed a role for GSK3 in the regulation
of Notch signal transduction. Specifically, phosphorylation of the Nicd by GSK3 results in
protein stabilization by blocking proteasomal degradation (Foltz et al., 2002).
Conversely, another study suggested that phosphorylation by GSK3 prevented proper
signal transduction by Notch in the nucleus (Espinosa et al., 2003). This represents and
interesting conundrum, but the prospects presented by each scenario indicate a
complex receptor-kinase interrelationship. Interestingly, GSK3 has been implicated in
regulating other pathways that are involved in neural progenitor proliferation (Wnt, Hh).
During neurogenesis, a body of evidence suggests GSK3 regulation of these pathways
is critical. Overall, it is implied that GSK3 activity is responsible for supporting
differentiation while inhibition allows progenitor proliferation (Hur and Zhou, 2010).
With respect to this thesis, the regulation of transcription factors is of particular
interest. Phosphorylation by GSK3 results in a number of potential outcomes similar to
the regulatory mechanisms employed by other systems. For example, in the case of βcatenin, sequential phosphorylation of the protein by GSK3 leads to destabilization via
proteasomal degradation (Aberle et al., 1997). Also, DNA binding ability can be
modulated by blocking physical interaction or preventing nuclear localization (Beals et
al., 1997; Neal and Clipstone, 2001). These regulations impinge upon transcription
factors that are important for development and neurogenesis.
Conclusion
This review of the literature describes the relationship protein kinase CK2 shares
with components of developmental pathways. As we have come to understand the
prolific nature of this kinase, it has also been realized that a more detailed
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understanding of factors regulated by CK2 is required. Additionally, investigation of
CK2 activities has opened new avenues of study regarding the post-translational
regulation of the E(spl) repressors. Therefore, in the subsequent chapter I will describe
in detail three new CK2 transcription factor substrates using bioinformatics to find CK2
consensus sequences, characterizing specific target residues by kinase assay, and
verifying CK2 as the active kinase. Then, I will describe a novel regulatory mechanism
involving 14-3-3 proteins and E(spl) repressors by identifying consensus sequences for
14-3-3 binding in divergent homologs and genetic analysis to evaluate biological
significance.
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Figure 1: Protein kinase CK2 is a rotationally symmetrical, multimeric enzyme composed of two
α(red)/β(blue and white) dimers. The dimers interface between the two regulatory β-subunits while the
catalytic α-subunits occupy distal points of the tetramer. The active site is positioned facing toward the β
subunit, which influences selectivity and reaction rates. Substrate targeting is specific to serine and
threonine residues located within acidic microdomains (highlighted). Addition of acidic phosphoryl-groups
can substitute for D/E, resulting in sequential phosphorylation. CK2 structure as determined by (Niefind
et al., 2001) (PDB: 1JWH).

	
  

36

Figure 2: Notch (N) mediated lateral inhibition is required for the specification of SOPs from a group of
equipotent precursors. This process is initiated at the interface of two cells that express the components
of Notch signaling (Δ (Dl) ligand = purple; N receptor = red). Here, the presumptive SOP has achieved a
higher level of atonal (ato) expression and therefore expresses higher levels of Dl than the adjacent cells.
In this way, N receptors on the non-SOP are activated and undergo proteolytic cleavage. This releases
icd
the N intracellular domain (N ), which translocates to the nuclease where it complexes with Supressor of
Hairless (Su(H)). Expression and post translational activation of E(spl)M8 antagonizes atonal
autoexpression, which indirectly lowers Delta. Ultimately, a single cell is designated as the SOP, which
establishes the adult organ.
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Figure 3: The E(spl)C encodes seven bHLH-Orange transcriptional repressors. Each repressor is
composed of four generalized domains. The basic domain (gray highlight) is required for interaction with
DNA while the HLH (green highlight) and the namesake Orange domain (orange highlight) allow
dimerization. Importantly, it has been posited that the C-terminal domain imparts a regulatory function.
Indeed, the obligate co-repressor Gro interacts with the invariant WRPW-motif (bold) while E(spl)Mδ
interacts with CtBP through its unique PVNLA (bold) sequence. Additionally, conserved phosphorylation
sites have been verified (CK2=red, MAPK=green) and others predicted (CK1 and GSK3=blue).
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Figure 4: (A) Specification of the Drosophila eye is initiated by expression of genes that compose the
retinal determination network (RDN, purple). Subsequently, the patterning of the retina is laid down about
a wave of differentiation, the morphogenetic furrow (MF). During proneural enhancement (stage 1) the
bHLH activator atonal is upregulated (orange to red) by Notch (N) and Hedgehog signalling. Then, lateral
inhibition (stage 2/3) restricts the R8 fate to a single cell (red). This single cell then progressively recruits
secondary photoreceptors (R1-R7) and accessory cells into the adult organ during stage 4. (B) Confocal
imagery of the morphogenetic furrow shows the stages of retinal patterning (Atonal = red; ‘R8’=green).
(C) The adult eye is composed of approximately 800 individual facets called ommatidia. Each unit eye
originates from a single R8 and is strictly patterned into a hexagonal array.
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Figure 5: The retinal determination network (RDN) is a set of transcriptional regulators whose expression
is required retinal development. Initially, twin of eyeless (toy) expression, activates eyeless (ey) which
drives expression of Sine Oculis (SO). This SIX family protein binds DNA, but requires Eyes Absent
(Eya) to elicit target gene expression. Progression through a complex system of regulatory relationships
leads to eye specification.
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Figure 6: (A) Bristles development begins with selection of the SOP from a group of equipotent cells that
express high levels of ASC bHLH activators (PNC). Excessive SOP density is restricted by interspersed
expression of emc, an antagonist of bHLH activators. Upon specification, the so-called pI then undergoes
a series of Notch signaling and E(spl)C dependent asymmetric divisions. Ultimately, four cells (neuron,
sheath, socket, and shaft) assemble into the adult organ. (B) Interommatidial bristles are present at
alternating vertices within the hexagonal array of the Drosophila eye. (C)The 22 macrochaetae of the
thorax are stereotypically patterned and bilaterally symmetrical about the long axis of the animal. The
microchaetae are dispersed in linear arrays on the notum except for the scutellum.
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Figure 7: 14-3-3 proteins regulate diverse cellular activities including signal transduction, transcription
factor localization, and chromatin structure by binding to phosphorylated substrates. The mechanisms by
which 14-3-3 renders its effects include steric occlusion of phosphatases, stabilization of complexes,
shifts in nuclear localization, and maintenance of a specific conformational state (molecular anvil
hypothesis).
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CHAPTER 2

Identification and Characterization of E(spl)Mγ, Extramacrochaetae and Sine
Oculis as targets for CK2
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ABSTRACT
Protein kinase CK2 phosphorylates and activates the bHLH protein E(spl)M8, an
effector of Notch signaling. This regulation has been studied during eye development in
the Drosophila model organism. The eye defects of CK2 hypomorphic mutants led us
to hypothesize that CK2 also targets other proteins involved in retinal histogenesis. The
studies described here employ bioinformatics and biochemistry to identify 3 new targets
of CK2; these are E(spl)Mγ, Extramacrochaetae and Sine Oculis, all of which are known
to be vital for proper retinal development. In addition, the site(s) of phosphorylation in
all 3 proteins have been identified, and sequence analysis reveals that these are
conserved in all Drosophila homologs, and in their vertebrate counterparts. Because
each of these proteins is expressed in a spatiotemporally distinct manner within the
developing eye, these studies expand the participation of CK2 to additional time points
of retinogenesis.
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INTRODUCTION
CK2 was identified in 1954 as the first enzyme that could phosphorylate another
protein and was originally called ‘protein phosphokinase’. It has since been shown that
this enzyme preferentially phosphorylates regions in proteins (or peptides) that are rich
in negatively charged (acidic) amino acids. Additionally, its prolific nature has become
apparent, with hundreds of known targets in eukaryotic proteomes. CK2, unlike other
kinases (PKA, PKC, etc.), does not respond to second messengers, but relies on
association with the regulatory CK2β-subunit to engender changes in activity and target
specificity, as well as through the formation of multiprotein complexes (Giot et al., 2003).
Though there are many questions left to be answered, it is known that CK2 functionality
is required during the most critical phases of the cell cycle, growth and development,
and rhythmic protein expression, and in all of these cases phosphorylation of the
relevant targets is spatially or temporally controlled. The mechanism underlying this
control remains to be revealed.
Some of the first biological experiments on CK2 were performed in the budding
yeast, Saccharomyces cerevisiae system. These investigations demonstrated the
requirement for CK2 during the cell cycle, as kinase deficient cells arrested during
intermediate phases (G1/S and G2/M) of cell division. In metazoans, the functional
conservation of CK2 becomes apparent because depletion of CK2 activity is lethal
during the early stages of metazoan development when cell proliferation rate is high,
and that CK2 has a role in later stages of embryogenesis when boundary formation and
organ development occur. Moreover, the importance of CK2 persists into the adult
organism where it is involved in regulating the circadian clock. It is through
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phosphorylation of a key oscillatory transcription factor Period (Per) that CK2 instigates
Per protein degradation and regulates timing of biological clocks in fungi, flies, and
mammals (Chiu et al., 2008; Duvall and Taghert, 2011; Menet and Rosbash, 2011;
Querfurth et al., 2011; Hubaud and Pourquie, 2013).
It is now widely recognized that CK2 maintains a central role in the regulation of
many transcription factors. During the cell cycle, CK2 phosphorylates p53 thereby
blocking its DNA binding and allowing progression through a critical checkpoint of the
cell cycle (Levine, 1997). Also, CK2 phosphorylates the homeodomain transcription
factor Antennapedia and prevents its cooperative DNA binding with Extradenticle during
early embryogenesis (Jaffe et al, 1997). More recent studies reveal roles for CK2 in cell
fate specification during neurogenesis through regulation of E(spl)M8, a repressor
whose activity is essential for development of the central and peripheral nervous
systems (Karandikar et al, 2004).
It is the role of CK2 during neurogenesis, spurred by the strong phenotypes
associated with E(spl)M8 and its CK2 site specific variants that have been the focus of
our laboratory. A direct role for CK2 in neurogenesis was revealed by the observation
that compromising CK2 activity leads to the specification of supernumerary sensory
organ precursors during bristle and eye development (Bose et al., 2006; Kunttas-Tatli et
al., 2009). These ectopic sensory organs are attributed to the loss of E(spl)M8 activity
(lateral inhibition), based on the similarity among Notch, E(spl), and CK2 loss of function
phenotypes. This intimate association between CK2 and the Notch signaling pathway
demonstrates the critical nature of CK2, and established that E(spl) proteins require
phosphorylation by CK2 to mediate the effects of Notch signaling. Given the variety and
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number of CK2 substrates, it seems likely that additional factors involved in
neurogenesis remain to be identified.
Using online bioinformatic tools to identify CK2 consensus sites, several
candidate proteins known to be involved in tissue patterning and neurogenesis were
identified. The first is a member of the E(spl) complex, E(spl)Mγ. Interestingly, its
predicted CK2 phosphorylation site is distinct from those identified in E(spl)M8, -M5 and
-M7. Additionally, the expression characteristics of E(spl)Mγ is markedly distinct from
E(spl)M8, -M5 and –M7. Therefore, the possibility is high that E(spl)Mγ plays a different
role during neural development. The second candidate, EMC, is a negative regulator of
the bHLH proneural activators (such as Ato, ASC) required for neuronal fate
specification and its CK2 site is conserved in the ID class of proteins from vertebrates
and invertebrates. Finally, SO, a member of the retinal determination network, is
required for eye formation and the site for CK2 is highly conserved in the homologs from
human and mouse, SIX1. Together, these findings implicate CK2 regulation at all
stages of eye neurogenesis and bristle development.
The studies described in this chapter identify and characterize the
phosphorylation of the aforementioned proteins by CK2, the role of the regulatory CK2β
subunit in these modifications, the sensitivity of these modifications to inhibition and
activation of CK2, and identification of the site(s) of phosphorylation. Subsequent
studies provide a foundation for future analyses in Drosophila and higher organisms so
that the role of CK2 in organismal growth, development and disease might be better
defined. The identification of EMC as a substrate of kinase phosphorylation represents
the first identified post-translational modification of the ID protein class.
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MATERIALS AND METHODS
Identification of Conserved CK2 Sites
Use of the sequence motif search tool at ‘prosite.expasy.org’ allowed the
identification of transcription factors involved in eye development that contain the amino
acid sequences commonly recognized by CK2. The primary sequences of the relevant
Drosophila orthologs were downloaded from the online database at ‘flybase.org’.
Compiled sequences were transformed into FASTA format for global alignment by the
MUSCLE online software using default parameter settings. Visual inspection of the
multiple sequence alignment revealed representative protein kinase CK2 targets (SD/E-X-D/E) that are highly conserved within the proteins being analyzed.
Isolation of the E(spl)Mγ Open Reading Frame
Single, wild type flies were ground in 50 µL genomic extraction buffer (10 mM
Tris, 1 mM EDTA, 250 mM NaCl, 0.2 µg/µL Proteinase K). The proteinase was heat
inactivated by incubation at 95 C for 5 minutes (Gloor et al. 1993). The E(spl)Mγ open
reading frame (ORF) was PCR amplified from the genomic extract using convergent
primers complementary to the 5’ and 3’ ends of the gene which contains no intronic
regions. The forward and reverse primers incorporated EcoR1 and Xho1 restriction sites
at the 5’ and 3’ ends, to allow for cloning into multiple vectors. Additionally, the forward
primer contained a Kozak sequence (double underlined) for efficient expression in
eukaryotic systems (CCCGAATTCAACATGTCGTCGCTACAAATGTCCGAGATGTCC,
CTCGAGCTACCAGGGACGCCAGACGTTCTCC). The PCR product was cloned into
PBS2(SK+) and the ORF was verified by sequencing.
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Mutagenesis of CK2 Sites in E(spl)Mγ, EMC, and Sine Oculis
Several variants of E(spl)Mγ, EMC and SO were generated for site mapping
using complementary primer sets which introduce alanine substitutions at the
appropriate serine/threonine residues. The respective open reading frames were
subjected to PCR amplification and the methylated template DNA was removed by
Dpn1 digestion. The remaining product was transformed into the E. coli DH5α strain.
Specific clones were sequenced for verification that only the intended mutations were
introduction.
Additional variants specific to the C-terminal regions of E(spl)Mγ (Gln134>Stop)
were generated using convergent primers. The forward primer included an EcoR1
restriction site and a Kozak sequence while the reverse primer contained an Xho1
restriction site. These variants included Mγ-CtD and Mγ-CtD-S195A, which were
generated using sequenced clones (MγS195A and Mγ) as template. All sequence and
structural variants generated were subcloned in frame pZEX or pMAL-c4x for
expression and affinity based protein purification.
Purification of GST-Fusion Proteins
pZEX plasmids expressing GST-Fusions were transformed into E. coli BL21 cells
containing pT-TRX, a thioredoxin expressing plasmid. Cell cultures were grown to a
target OD600 of 0.7 in 2xYTA containing 150 µg/mL ampicillin and 15 µg/mL
chloramphenicol. Protein expression was induced using a final concentration of 1 mM
IPTG at 30 C with vigorous shaking for approximately 3 hours. Cells were harvested by
centrifugation and resuspended in 8 mL of phosphate buffered saline containing 5 mM
EDTA, 0.1 mM PMSF and 0.2% β-mercaptoethanol. Cells were treated with lysozyme at
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a concentration of 1 mg/mL on ice for 30 minutes followed by pulse sonication for
approximately 30 seconds. Nearly complete lysis was verified by phase contrast
microscopy. Subsequently, 10% Triton-X 100 was added to a final concentration of 1%
and the lysed fraction was incubated at 4 C for approximately 1 hour. Insoluble
components were precipitated by centrifugation. The GST-protein supernatant was
applied to 4% agarose matrix crosslinked to reduced glutathione (MCLabs) and
incubated at 4 C with nutation for ~2 hours. The bead matrix was then washed with 10
bed volumes of phosphate buffered saline containing 5 mM EDTA and 0.1 mM PMSF.
Bound protein was eluted in five 1 mL fractions of elution buffer(15 mM reduced
glutathione, 50 mM Tris pH-8.0). Pooled fractions were then concentrated and
exchanged into storage buffer (10 mM Tris pH-8.0, 0.5 mM EDTA, 5% glycerol, 150 mM
NaCl, 0.1 mM PMSF, 0.02% Sodium Azide) using an Amicon Ultra-15 10K device
(10,000 MWCO). Stability and purity were confirmed by SDS-PAGE and concentration
was estimated by comparison to known BSA standards.
Purification of MBP-Sine Oculis
pMAL-c4x plasmids expressing MBP-Fusions were transformed into E. coli BL21
cells containing pT-TRX, a thioredoxin expressing plasmid. Cell cultures were grown to
a target OD600 of 0.7 in 2xYTA containing 150 µg/mL ampicillin. Protein expression was
induced using a final concentration of 1 mM IPTG at 30 C with vigorous shaking for
approximately 3 hours. Cells were harvested by centrifugation and resuspended in 8 mL
of phosphate buffered saline containing 5 mM EDTA, 0.1 mM PMSF and 0.2% βmercaptoethanol. Cells were treated with lysozyme at a concentration of 1 mg/mL on
ice for 30 minutes followed by pulse sonication for approximately 30 seconds. Nearly
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complete lysis was verified by phase contrast microscopy. Subsequently, 10% Triton-X
100 was added to a final concentration of 1% and the lysed fraction was incubated at
4C for approximately 1 hour. Insoluble components were precipitated by centrifugation.
The MBP-protein supernatant was applied to amylose resin (NEB) and incubated at 4C
with nutation for ~2 hours. The bead matrix was then washed with 10 bed volumes of
column buffer (20 mM Tris-HCl, pH 7.4, 0.2 M NaCl, 1 mM EDTA, 1 mM DTT and 0.1
mM PMSF). Bound protein was then eluted in five 1mL fractions using column buffer
supplemented with maltose (10 mM). Pooled fractions were then concentrated and
exchanged into storage buffer (10 mM Tris pH-8.0, 0.5 mM EDTA, 5% glycerol, 150 mM
NaCl, 0.1 mM PMSF, 0.02% Sodium Azide) using an Amicon Ultra-15 10K device
(10,000 MWCO). Stability and purity were confirmed by SDS-PAGE and concentration
was estimated by comparison to known BSA standards.
Protein Kinase CK2 Phosphorylation Assay
Each kinase reaction was performed at approximately 25C in 50 mM Tris, pH 8.5
100 mM NaCl, 10 mM MgCl2, 10 µM ATP, 2.5 µCi of [γ-32P]ATP and ~2 µg of the
respective GST or MBP-Fusion of E(spl)Mγ, EMC, and Sine Oculis proteins in a total
volume of 40 µL. The reaction was initiated with the respective enzymes (dCK2α or
CK2-HoloE) to a final concentration of 0.5 ng/µL using 5 µL of 4 ng/mL kinase solution
in 20 mM Tris, pH 8.0, 0.4 mM EDTA, 200 mM NaCL, 10% glycerol, 0.5 mM DTT, and
0.05% Triton X-100. The individual modulators were added to the reactions such that
the final concentrations were GTP (60 µM), heparin (1 µg/mL), protamine (125 µg/mL),
spermine (500 µg/mL) and poly-lysine (100 µg/mL). Reaction termination was achieved
using 10 µL 5x sample buffer (312 mM Tris-Cl, pH 6.8, 10% SDS, 25% β-
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mercaptoethanol and 40% glycerol) and boiled for 10 minutes. Samples were resolved
by SDS-PAGE using the Laemmli system and stained with Coomassie. Radioactivity
was detected using BlueDevil FilmTM and developed using Kodak GBX developer and
fixer.
Structural Prediction of Sine Oculis
The primary sequence of SO was downloaded from ‘flybase.org’ and submitted
to the iTASSER online 3D structural prediction software (Zhang, 2008; Roy et al., 2010).
Additionally, the serines of SO determined to be targets of protein kinase CK2 (Ser290-292
and Ser294) were changed to phosphomimetic aspartate residues. The two highest
scoring structures were then compared using the SwissPDB Viewer.
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RESULTS AND DISCUSSION
E(spl)Mγ
Computational Identification of E(spl)Mγ as a potential target for CK2
The primary sequences of E(spl)Mγ were obtained from flybase.org and aligned
using the online software 'MUSCLE'. These sequences represent approximately 50 myr
of Drosophila evolution and include 13 species. It was found that E(spl)Mγ from all 13
species contain three highly conserved consensus sites for CK2 (Fig. 1). Two of these
sites (Thr45 and Ser48) are located within the loop of the HLH domain that immediately
follows the N-terminal basic motif. It is of interest to note that of the seven E(spl) bHLHO proteins, E(spl)Mγ is the only member to contain a potential site for CK2 within the
HLH (see Fig. 3, Ch. 1). The second site (Ser195) is located near the C-terminal WRPW
motif and is notable because this region is especially rich in acidic amino acids (D/E) a
hallmark of 'high likelihood' targets of CK2. In contrast, the N-terminal CK2 sites
present the possibility of hierarchical phosphorylation, i.e., phosphorylation of Ser48 is
predicted to lead to substrate modification of Thr45.
Phosphorylation of E(spl)Mγ by CK2
To determine if E(spl)Mγ is phosphorylated by CK2, two forms of the enzyme
were employed. These include monomeric Drosophila CK2α (dCK2α) purified from
yeast lacking endogenous CK2 genes and rescued by a cDNA encoding dCK2α (Bidwai
et al., 1992), and native α2β2 holoenzyme (CK2-HoloE) purified from Drosophila
embryos. Both preparations are essentially pure based on Coomassie staining (Fig. 2).
The weak stain of CK2β relative to CK2α (Fig. 2) does not reflect sub-stoichiometric
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CK2β, but instead weak staining of this phosphoprotein, which has been noted earlier
(Bidwai et al., 1992).
The two isoforms of CK2 were used to determine if phosphorylation of E(spl)Mγ
is promoted or inhibited by CK2β, as has been observed for other proteins. In these
assays, 20 ng of dCK2α or CK2-HoloE were used and consequently proteins with the
mobility of dCK2-α/β are not discernable in SDS-PAGE gels stained with Coomassie
(Fig. 2, top). E(spl)Mγ was purified as a GST fusion, while GST-alone and GSTE(spl)M8 were used as negative and positive controls, respectively. As shown in Figure
2, E(spl)Mγ was robustly phosphorylated by dCK2α and CK2-HoloE. Phosphorylation is
specific to E(spl)Mγ as GST-alone was not modified by either isoform. A comparison of
the band intensities reveals that CK2-HoloE phosphorylates E(spl)Mγ to a greater
extent than that with dCK2α. This difference more likely reflects greater activity of the
holoenzyme, rather than a requirement for CK2β. Phosphorylation of E(spl)M8 (positive
control) was also observed with both isoforms, although the presence of CK2β appears
to diminish the extent of phosphorylation. Thus, like E(spl)M8, E(spl)Mγ is an in vitro
target for CK2.
Map the CK2 site(s) in E(spl)Mγ
Because E(spl)Mγ harbors multiple CK2 consensus sequences, the protein was
dissected to identify sites that are phosphorylated in vitro. The protein was divided into
two regions. The first, E(spl)Mγ*, represents the N-terminus through the end of the
Orange domain (Fig. 3), whereas the second, E(spl)Mγ-CtD, represents sequences
from the end of Orange to the WRPW motif (Fig. 3). These two regions isolate the CK2
sites within the HLH from the one proximal to the WRPW motif. Constructs were
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generated by PCR and verified by sequencing (Fig. 3). In addition, site directed
mutagenesis was used to replace potential CK2 phosphoacceptors with Ala to generate
non-phosphorylatable variants. All of these variants have been verified by sequencing
(Fig. 3).
E(spl)Mγ variants were purified to homogeneity and phosphorylated using CK2HoloE as described above. Because the CK2β subunit does not inhibit targeting of
E(spl)Mγ, phosphorylation reactions employing dCK2α were deemed unnecessary for
mapping studies. In brief, 20 ng of CK2-HoloE was used to phosphorylate 0.5-1.0 µg of
E(spl)Mγ variants under conditions (steady state) where enzyme activity is linear with
time. GST-alone was used as a negative control. As shown in Fig. 3, Mγ-CtD was
efficiently phosphorylated by CK2, a reaction that was completely blocked by replacing
Ser195 with Ala. This absence of phosphorylation is seen even though equivalent
amounts of Mγ-CtD and its S195A variant were used in the assays (Fig. 3, see gel).
Furthermore, Ser195 appears to be the primary site for phosphorylation by CK2, as its
replacement with Ala in full-length Mγ also blocked phosphorylation (Fig. 3, see FLS195A). To independently verify that CK2 does not target sites in the HLH, studies were
conducted with Ala variants at Ser48 and Thr45 in E(spl)Mγ*. While E(spl)Mγ*-S48A was
weakly phosphorylated, neither E(spl)Mγ*-T45A nor E(spl)Mγ*-T45+S48A were
phosphorylated. It is unlikely that the faint band seen for E(spl)Mγ*-S48A reflects
modification of Thr45, because full-length E(spl)Mγ with the S195A mutant displays no
such baseline phosphorylation. It is therefore more likely that the faint band with
E(spl)Mγ*-S48A is an in vitro artifact. Thus, E(spl)Mγ is modified only at Ser195 by CK2.
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Modulate CK2 targeting of E(spl)Mγ
It remained possible that a minor enzyme contaminant from either the CK2HoloE preparation or the GST-E(spl)Mγ purification was responsible for the observed
phosphorylations. To exclude this possibility, the CK2-HoloE phosphorylation of GSTE(spl)Mγ wild type protein was tested in the presence of various small molecule
competitors (GTP), inhibitors (Heparin), or polybasic activators (Fig. 4).
First, the unusual property that CK2 can use GTP as an alternative
phosphodonor was exploited. In this assay, phosphorylation reactions contained [γ32P]ATP at a concentration of 15 µM (1xKm), but were supplemented with cold-GTP at a
concentration of 60 µM. In this assay, cold-GTP would compete with [γ32P]-ATP,
resulting in a decrease in phosphorylation, but only if the enzyme is CK2. Indeed, GTP
(60 µM) decreases 32P-incorporation into GST-E(spl)Mγ. Likewise, the oligosaccharide
heparin (1µg/mL), a CK2 specific inhibitor, also effectively diminished phosphorylation of
GST-E(spl)Mγ.
It has been previously shown that polybasic compounds interact with negatively
charged residues in the CK2β subunit and thereby stimulate the activity of CK2-HoloE.
In these experiments reactions were conducted in the presence of, protamine, spermine
and poly-lysine (125 µg/mL, 500 µg/mL, and 100 µg/mL, respectively). It was found that
these compounds modestly increase phosphorylation of GST-E(spl)Mγ. Because GSTalone is not phosphorylated by CK2-HoloE in the absence of these effectors (Fig. 4), or
in their presence (Trott et al., 2001a; Trott et al., 2001b), the phosphorylation sites are
specific to the E(spl)Mγ fusion component and the associated modulation of kinase
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activity is consistent with CK2. Taken together, these studies confirm E(spl)Mγ as a
bona fide substrate of CK2.
Extramacrochaetae
Computational Identification of EMC as a potential target for CK2
The primary sequences of 11 Drosophila EMC orthologs were downloaded from
flybase.org and aligned using the online software ‘MUSCLE’ (Fig. 5). From this
alignment, two CK2 consensus sites were identified. The first site lies near the Cterminal end of the HLH within the sequence T77-E-L-E. This motif is invariable among
the 11 Drosophila homologs analyzed (Fig. 5). The second site, located approximately
30 residues C-terminal of the HLH, is in a highly acidic region characteristic of CK2
target sites. This feature makes this site a primary candidate for CK2 phosphorylation.
Though the latter site is variable in both sequence and position (Fig. 5), the persistence
of these two consensus motifs through 50 myr of evolution is suggestive of
phosphoregulation in a region near the HLH.
Interestingly, the human homolog ID1 maintains a CK2 site immediately after the
second helix of the HLH, analogous to one of the two sites in Drosophila homologs at
Thr77 (Homo sapiens ID1, Fig. 5). Interestingly, the CK2 site in hsID1 is known to be a
phosphoprotein based on mass-spectroscopic analysis (Mayya et al., 2009). The
conservation of the CK2 site and its position in EMC/ID1 raise the likelihood that this
motif is of regulatory importance.
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Phosphorylation of EMC by CK2
The two isoforms of dCK2 (described above, see Fig. 3) were used to determine
if EMC is a target for this protein kinase. To this end, EMC was purified as a GSTfusion while GST-alone and GST-E(spl)M8 served as positive and negative controls,
respectively. Qualitatively, CK2α and CK2-HoloE have similar kinase activities with
respect to EMC, revealing that targeting of this protein is neither dependent upon CK2β
nor inhibited by it (Fig. 6). GST-alone was not phosphorylated by either CK2 isoform,
indicating that phosphorylation is specific to EMC. Similarly, phosphorylation of
E(spl)M8 occurred in the presence of both kinase isoforms, though the CK2-HoloE
produced significantly less phosphoprotein as previously described (see above, Fig.2).
These results reveal that EMC is targeted by CK2.
Map the CK2 site(s) in EMC
EMC contains multiple CK2 consensus sequences and thus required the
generation of non-phosphorylatable variants to identify which of these are targeted in
vivo. Site directed mutagenesis was used to substitute Ala for Thr77 (T77A) and Ser106
(S106A) individually or in combination (T77A+S106A) (Fig. 7). All mutants were verified by
sequencing.
The aforementioned EMC-variants were purified as GST-fusions and their ability
to be phosphorylated was tested using the CK2-HoloE. Equivalent amounts of wild-type
and mutant proteins were used in the phosphorylation experiments (Fig. 7, gel). While
WT-EMC was robustly phosphorylated, the T77A+S106A mutant was refractory.
Additionally, substitution of Ser106, but not Thr77, caused complete loss of 32P-
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incorporation. In these assays, GST-alone was not targeted by CK2. These
experiments confirm that Ser106 is the sole CK2 phosphoacceptor in EMC.
Modulate CK2 targeting of EMC
The possibility that a contaminating enzyme is responsible for phosphorylation
was addressed using specific modulators of CK2 function. GST alone was used as a
negative control and exhibited no detectable phosphorylation (arrow, Fig. 8). GTP (60
µM) and heparin (1 µg/mL) were used to compete with [γ32P]ATP as substrate and
attenuate kinase activity, respectively. It was found that both of these molecules
decrease the phosphorylation of wild-type EMC in their respective reactions (Fig. 8).
Conversely, the polybasic activators protamine (125 µg/mL) and spermine (500 µg/mL)
did not enhance phosphorylation of EMC (Fig. 8), whereas poly-lysine resulted in a
slightly decrease in phosphorylation. This is the first example of poly-lysine causing a
decreased phosphorylation of a protein and the reasons remain unclear. Taken
together, these results authenticate the phosphorylation of EMC by CK2 and provide a
foundation for future analysis in vivo.
Sine Oculis
Computational Identification of Sine Oculis as a potential target for CK2
Drosophila Sine Oculis (SO) contains a stretch of 4 serines in an acidic motif that
lies in the vicinity of the homeodomain (Ser290 to Ser294 Fig. 9A). Ser292 and Ser294 fit
the strict CK2 consensus, while Ser290 and Ser291 are candidates for hierarchical
phosphorylation originating from the former high affinity sites (Figure 9A). It is
interesting that these orthologs are highly conserved throughout the homeodomain and
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CK2 motif but little conservation exists in regions immediately C-terminal (Figure 9A and
not shown). Additionally, human homologs of fly SO, i.e. SIX1 and SIX2, maintain these
CK2 sites, though they have been displaced toward the C-terminus by several residues
(Figure 9B). Because the SIX1 and SIX2 phosporylation sites have become displaced
from the primary DNA interacting helix of the homeodomain, it is possible that a more
complex conformational shift accounts for changes in DNA binding affinity. Regardless,
extensive site conservation marks CK2 as a prime regulator of SO/SIX activity. While
previous work has demonstrated that CK2 phosphorylation prevents DNA binding by
SIX1 (Ford et al., 2000), little is known about the CK2 targeting of the Drosophila
homolog or the consequences in vivo.
Phosphorylation of Sine Oculis by CK2
GST-fusions of SO were not used because of excessive susceptibility to
degradation (data not shown). Moreover, it has been found that human SIX1 cannot be
purified as a GST-fusion, but can be when fused to maltose binding protein (MBP).
Even when purified as an MBP-fusion, SO displays three major and several minor
bands on SDS-PAGE gels stained with Coomassie (Fig. 10, gel). These bands are
seen despite the presence of protease inhibitors and likely reflect degradation in vivo (E.
coli). This problem has also been encountered with human SIX1 (Hieda Ford, personal
communication).
The two isoforms of dCK2 (described above, Fig. 3) were used in kinase assays
to test of isoform specificity. To determine if SO is a target of CK2, MBP-SO was
purified to homogeneity along with the negative and positive controls MBP-alone and
GST-M8. While MBP-alone was not phosphorylated by either dCK2α or CK2-HoloE,
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GST-M8 displayed higher levels of phosphorylation by the monomeric catalytic subunit
(Fig.10). The purified MBP-SO was unstable and multiple degradation products are
visible in Coomassie staining. It is clear CK2α and CK2-HoloE robustly phosphorylate
SO, indicating that targeting is independent of CK2β. Additionally, because only the two
largest products are phosphorylated by CK2, it is likely that the observed degradation
originates from the C-terminus. These results demonstrate that SO is a substrate of
CK2.
Map the CK2 site(s) in Sine Oculis
To identify the residues of SO that are phosphorylated, three substitution variants
containing alanine at the relevant positions were generated by site directed
mutagenesis and verified by sequencing (data not shown). The wild type protein
contains the sequence motif S290SSDSEME297 that was targeted for mutagenesis. The
mutants that were generated are S290+291A (AASDSEME), S292+294A (SSADAEME) and
S290+291+292+294A (AAADAEME). These variants were purified to homogeneity as MBPfusions and each exhibit instability comparable to the wild type protein, as described
above.
Phosphorylation reactions were conducted using only the CK2-HoloE, because
both isoforms of CK2 exhibit equivalent activities. Also, identical amounts of protein
were used though the S292+294A variant appears to be slightly less abundant (Fig. 11,
gel) MBP-alone (negative control) nor the S290+291+292+294A were phosphorylated by the
CK2-HoloE, verifying that kinase activity is specific to the computationally predicted
motif (Figure 11). Both wild type SO and S290+291A exhibit equivalent and high levels of
phosphorylation establishing Ser292 and Ser294 as CK2 targets. Low levels of
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phosphorylation that was observed for the S292+294A variant positively identified
phosphorylation of Ser290 and Ser291. A modest decline in radioactivity for S290+291A as
compared to wild type protein serves as an indication that Ser290 and Ser291 are
phosphorylated. The phosphorylation of Ser290 and Ser291 independent of
phosphoaddition to Ser292 and Ser294 demonstrates that modification of the former is not
exclusively hierarchical (see Ch. 1, Fig. 3 and Ch. 2, Fig. 11). However, it is likely that
acidification of the region through phosphorylation of the high affinity sites (Ser290 and
Ser291) enhances targeting of the Ser residues nearby. Thus, it has been demonstrated
that the residues in the conserved CK2 consensus motif are phosphorylated in vitro.
Modulate CK2 targeting of Sine Oculis
The possibility remained that a contaminating enzyme from the MBP purification
or CK2 kinase preparations was responsible for the observed phosphorylations. To
eliminate this possibility, cold GTP (60 µM) and the CK2 specific inhibitor heparin
(1µg/mL) were used to compete with [γ32P]ATP as substrate or inhibit enzyme activity,
respectively. It was found that the addition of GTP potently decreases the levels of
radioactivity incorporated into MBP-SO. Unexpectedly, heparin did not inhibit the CK2
reaction as expected, instead the levels of radioactivity increased (Fig. 12). The
possibility is likely that this is an experimental artifact.
I next tested if SO phosphorylation was modulated by the poly-basic activators.
Protamine (125 µg/mL) and spermine (500 µg/mL) did not further increase
phosphorylation of MPB-SO as compared to the unmodulated reaction (Fig. 12). In
contrast and unexpectedly, poly-lysine (100 µg/mL) dramatically decreased
phosphorylation of SO (Fig. 12). This effect was greatest with the high molecular weight
	
  

62

rather than the low molecular weight degradation product. These results are
inconsistent with expectation and may reflect a procedural error whereby the heparin
and poly-lysine modulated reactions was interchanged. The results of the isoform and
mapping experiments together, demonstrate that CK2 is a potent post-translational
modifier of SO.
Structural insights into CK2 regulation of Sine Oculis
Ford et al. (2001) demonstrated that human SIX1 phosphorylation by CK2
abrogates DNA binding. This is likely due, in part, to the proximity of the
phosphorylation sites to the nearly invariant DNA binding helix of the homeodomain.
However, the mechanism by which DNA binding is altered by phosphorylation has
remained unexplored. To make inferences about the underlying mechanism, the wildtype primary sequence and the phosphomimetic version (S290+291+292+294D) were
submitted to the iTASSER structural prediction software (Zhang, 2008; Roy et al.,
2010). The algorithm produced very similar outputs for the two sequences. However,
one striking difference is the rotation of an α-helix in the C-terminal region of the SIX
domain (Fig. 13). Upon further inspection, the last α-helix of the SIX domain (hereafter
α-6), nearest the N-terminus of the homeodomain, contains a number of basic residues,
similar to a basic motif present in DNA binding molecules.
BindN+, a bioinformatics tool that predicts DNA binding based on primary
sequence, indicates that α-6 is an excellent candidate for protein-DNA interface (Fig.
13). Moreover, DISPLAR, which takes into account 3D structural features in predicting
DNA interaction, identifies α-6 as a potential DNA interactor for both models (not
shown). These findings are suggestive of an incomplete understanding of SIX family
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protein function and regulation. It could be that the α-6 helix is important for stable
formation of the SO/Eya complex with DNA. Alternatively, CK2 phosphorylation may
block DNA interaction through the homeodomain while simultaneously unmasking α-6
for DNA binding. This effect could change the sequence specificity of the transcriptional
activation complex. As these data are predictive, biochemical and genetic analysis are
needed to provide direct evidence for these inferences.
SIGNIFICANCE
CK2 and the regulation of E(spl)Mγ
The phosphorylation of E(spl)Mγ by CK2 brings to four the number of E(spl)C
repressors targeted by this kinase. While E(spl)M8 has been studied at length and the
autoinhibition model is supported by trans-inhibition of hypermorphic variants (Kahali et
al., 2010), a similar molecular mechanism can not be transposed to E(spl)Mγ. Though
all CK2 sites are located in the CtD of these repressors, the relative location in E(spl)Mγ
is distinct in that it is juxtaposed to the WRPW. Given the proximity of this kinase site to
the Gro interaction motif, a simple and eminently testable hypothesis is that CK2
influences co-repressor (Gro) binding capacity. If this were the case, CK2 would serve
to inhibit E(spl)Mγ repressor activity, an effect opposite that observed in the case of
E(spl)M8.
Additionally, alignment of distant homologs indicates the continual presence of
the ‘PLSP’ sequence motif may be of importance. Kinases that have demonstrated
preferential targeting of this sequence motif include a number of cyclin dependent
kinases (CDKs), mitogen activated protein kinases (MAPKs), and GSK3. In E(spl)M8,
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phosphomimicry at an analogous motif, in both sequence and position, leads to a more
potent repressor activity (Bandyopadhyay, personal communication).
It seems as though the complement of kinases that target the E(spl) repressors
that are active during eye development has been conserved to some extent (CK2,
MAPKs etc.). However, the associated consequences may be varied. For example, if
the phosphorylation of E(spl)Mγ prevents binding of the corepressor Gro, dimerization
with other repressors could negatively regulate repression. Alternatively, formation of a
stable complex between E(spl)Mγ and Gro might serve as a regulatory mechanism for
the timing of transcriptional events. Genetic testing and biochemical studies will be
required to evaluate these hypotheses.
CK2 and the regulation of Extramacrochaetae
While previous high throughput studies have indicated that the human ID1 is
phosphorylated at an analogous site, the identification of CK2 as a post-translational
modifier of EMC/ID1 is the first of its kind. It can be seen that the region in which the
Drosophila CK2 sites are located have experienced insertion or deletion (indel) events
(Fig.5). However, the resilience of the CK2 site in both proteins, along with the
phosphorylation status of human ID1 (see above), suggests an important regulatory
function, yet to be fully understood. For Drosophila, it is difficult to infer a simple
mechanism because the region of phosphorylation tends to be hyper-acidic. However,
when considering the conservation of a CK2 site near the C-terminus of the stereotyped
HLH in ID1, it seems reasonable to estimate that dimerization involving EMC/ID1 and
other HLH proteins is being modulated. If so, phosphorylation could establish a
negatively charged surface that forms stabilizing interactions with the basic domain of
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target proteins or other regions through charge interactions such as salt bridges.
Conversely, phosphorylation may block the ability of EMC/ID1 to form stable
interactions due to conformational alteration or steric hindrance.
These findings have interesting implications for a number of developmental
processes in Drosophila. First, EMC is known to be required for the formation of tubular
structures in the wing and digestive tract, an as yet unexplored role for CK2. Also, a
relationship between EMC and CK2 during neurogenesis is a new and critical
association. This is because regulation of morphogenetic furrow movement is strongly
dependent upon EMC and could be post-translationally controlled by CK2. With respect
to bristle development, EMC loss of function yields ectopic macrochaetae (Ellis et al.,
1990; Garrell and Modolell, 1990; Cubas et al., 1994), as does CK2 loss of function
(Bose et al., 2006). This is likely a direct consequence of enhanced proneural activity
and compromised lateral inhibition, respectively. However, phospho-regulation of EMC
could be an additional, underlying mechanism that drives the observed effects of CK2
deficiency. Combinations of emc and CK2 alleles would allow for assessment of their
genetic interactions.
Extension of these findings into the human system is a paramount aspect of
future studies, because this single phosphorylation may have relevance in
understanding the development of disease states. For example, ID1 is an involved
factor during angiogenesis, which is required for the survival of large, often invasive
tumors (Lyden et al., 1999). Additionally, expression of ID1 expression is commonplace
in neoplastic tissues as it prevents the onset of differentiation. Therefore, analysis of
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EMC/ID1 will contribute to an understanding of why inhibition of CK2 may be
contraindicated or aid in the chemotherapeutic inhibition of cancerous growth.
CK2 and the regulation of Sine Oculis
As it is for SIX1, phosphorylation of SO by CK2 is likely a critical regulatory
event. Specifically, during eye development, DNA binding and transcriptional activation
by the SO/EYA complex is an area of immediate investigation. The consequences of
this are yet to be analyzed, but the failure to accomplish retinal determination is a
potential outcome. The investigation of this question is possible using specific
expression of the mutants in the relevant tissues and time points via the UAS-GAL4
system. Based on the effects of variants that mimic constitutively phosphorylated SO
(Asp substitutions) or those that are refractory to phosphorylation by CK2 (Ala
substitutions, see above), a more detailed understanding of the in vivo consequences
underlying CK2 phosphorylation of SO can be acquired.
Structurally, phosphorylation by CK2 may instigate conformational changes,
which shift the DNA binding of SO/SIX1 from the homeodomain to the SIX-domain.
Previous assessments of DNA binding have used double stranded oligonucleotides
whose sequence is homeodomain specific (Hazbun et al., 1997; Ford et al., 2000; Liu et
al., 2012). This result makes sense for SIX1, as the CK2 phosphorylation sites are in
close proximity to the conserved primary DNA binding helix of the homeodomain.
However, the DNA interaction of the α-6 helix remains undetermined. Based on the
high density of basic residues in this helix, the ability to interact with DNA is inferable.
This idea is further supported by the observation that SIX1 mutants causing the
condition known as BOR syndrome contains amino acid substitutions in α-6 that replace
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a number of the basic residues (Patrick et al., 2009). These mutants are deficient in
DNA binding activity as assessed for the homeodomain. Moreover, analysis has
indicated that slight variations at specific primary sequence positions in the α-6 helix
account for distinguished sets of cofactor interactions (Kenyon et al., 2005). Therefore,
it seems that a source of functional variation among SIX proteins resides in this specific
helix and, for SIX1/SO, this could include shifts in DNA binding specificity.
The regulation of DNA binding by SO/SIX1 by CK2 has important implications for
cancer onset and progression. Indeed, many neoplastic tissues overexpress both SIX1
and Eya (reviewed in (Christensen et al., 2008)). Additionally, CK2 phosphorylation of
SIX1 has been shown to occur in mitotically active cells (Ford et al., 2000). Therefore, a
complete understanding of the regulatory mechanism underlying SO/SIX1 DNA binding
and transcriptional regulation is important for understanding not only the retinal
determination network, but also oncogenesis and other diseases in humans.
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Figure 1: The sequence alignment of E(spl)Mγ homologs reveals CK2 sites in two disparate locations of
48
the protein. The first site is located within the HLH at Ser . Phosphorylation of this residue could
45
increase local acidity sufficiently to stimulate modification of N-terminal residues, in this case Thr . An
additional site exists in the C-terminus of the protein near the WRPW. Here, Ser195 is positioned in a
region of acidic residues, making it a likely target of CK2. The positioning of this phosphorylation site so
near the WRPW co-repressor binding motif raises the possibility of repressor inhibition or activation as a
consequence of CK2 targeting. Drosophila melanogaster (Dmel), D. willistoni (Dwil), D. pseudoobscura
(Dpse), D. ananassae (Dana), D. yakuba (Dyak), D. sechellia (Dsec), D. simulans (Dsim), D. erecta
(Dere), D. grimshawi (Dgri), D. mojavensis (Dmoj), D. virilis (Dvir).	
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Figure 2: The CK2 isoforms used in these studies are highly pure and stable as observed by Coomassie
staining. The negative control (GST, arrow) displays no radioactivity and therefore is not a target of CK2.
The positive control, E(spl)M8 exhibits robust phosphorylation in the presence of both CK2 isoforms,
demonstrating that the kinase is active. Here, it can be seen that CK2 recognizes E(spl)Mγ as a
substrate and this targeting is enhanced by the β-subunit. Asterisk (*) = β-subunit autophosphorylation.
Boxes = E(spl)M8 degradation. Arrow = GST.
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Figure 3: Due to multiple CK2 sites in E(spl)Mγ, it was necessary to disect the protein in order to
determine which sites are phosphoacceptors. The scematic shows the respective CK2 sites and the
fragments used to isolate candidate residues. Here, the reactions reveal that the sites within the HLH are
not targeted in the full length repressor and only mildly it the absence of the CtD. Conversely, the Cterminal site proximal to the ‘WRPW’ motif is robustly phosphorylated and likely serves as a regulatory
switch in vivo.
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Figure 4: Direct modulation of CK2 activity verifies that a contaminating kinase is not confounding the
observations. Both GTP (60 µM) and heparin (1µg/mL) compete with radioactive ATP as substrate as
both reactions display lowered band intensity. On the other hand, the polybasic activators protamine (125
µg/mL), spermine (500 µg/mL), and poly-lysine (100 µg/mL) show comparable or increase rates of
substrate turnover. Taken together, these experiments justify calling E(spl)Mγ a CK2 substrate.
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Figure 5: The Drosophila EMC orthologs contain two consensus sequences for CK2, one located at the
end of the HLH (TELE) and another in approximately thirty (30) residues C-terminal to the HLH (yellow
and red). The former site is invariant while the latter is positioned in a region of considerable variability.
Conservation of the site suggests an important regulation. The Homo sapiens ID1 (top line) contains a
CK2 site juxtaposed to the HLH. Drosophila melanogaster (Dmel), D. willistoni (Dwil), D. pseudoobscura
(Dpse), D. ananassae (Dana), D. yakuba (Dyak), D. sechellia (Dsec), D. simulans (Dsim), D. erecta
(Dere), D. grimshawi (Dgri), D. mojavensis (Dmoj), D. virilis (Dvir).
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Figure 6: The two isoforms of CK2 were tested for their ability to phosphorylate EMC. It can be observed
that the GST tag is not phosphorylated (arrow+box) and the respective kinases behave as expected with
respect to E(spl)M8, which has degraded (box). For EMC, both the monomeric kinase and the
holoenzyme are effective modifiers of the protein.
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Figure 7: To resolve the specific EMC residues modified by CK2, a set of alanine substitutions was
77
106
generated for the two described consensus sites. The T +S A mutant does not exhibit phosphorylation
106
verifying that only the suspect sites are potential targets. Because the S A mutant is not
77
phosphorylated but the T A mutant is phosphorylated, it has been determined that only one residue is
targeted by CK2. The GST tag is not phosphorylated by CK2 (arrow+box).
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Figure 8: To verify that CK2 was the kinase involved in the observed kinase reactions, specific
modulators of its activity were used in congruent reactions. It can be seen that both GTP (60 µM) and
heparin (1µg/mL) were able to decrease the level of turnover in their respective reactions. In contrast the
polybasic activators protamine (125 µg/mL) and spermine (500 µg/mL) maintained or enhanced enzyme
activity. Quizzically, the poly-lysine (100 µg/mL) reaction showed lowered kinase function.
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Figure 9: (A) The homeodomain and CK2 sites of Drosophila SO are highly conserved. These sites are
very near the DNA binding Helix-3 of the homeodomain and potentially undergo hierarchical
phosphorylation (B) The mammalian homologs SIX1 and SIX2 share the CK2 sites, though they are
displaced toward the C-terminus. Drosophila melanogaster (Dmel), D. willistoni (Dwil), D. pseudoobscura
(Dpse), D. ananassae (Dana), D. yakuba (Dyak), D. sechellia (Dsec), D. simulans (Dsim), D. erecta
(Dere), D. grimshawi (Dgri), D. mojavensis (Dmoj), D. virilis (Dvir).
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Figure 10: Initial experiments using MBP as substrate suggest that both isoforms are capable of
modifying CK2. Based on the differential band intensity between the monomer and holoenzyme, it
appears that the β-subunit enhances targeting by CK2. The smaller degradation product of SO (asterisk)
is not phosphorylated, whereas the larger peptides maintain affinity (arrows). E(spl)M8 in the presence of
holoenzyme is just observable in the film due to the short exposure time and MBP is not phosphorylated
(arrow+box).
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Figure 11: The potential for hierarchical phosphorylation of SO remained undetermined. Using various
alanine substitutions the serine residues modified by CK2 was determined. Here, the alteration of all
serines results in an unmodified protein and verifies that only the suspect residues are targeted. The
290+291
S
A mutant exhibits comparable phosphorylation to wild-type while CK2 maintained slight affinity for
292+294
the S
A mutant. These findings suggest that at least three of the serine residues are phosphorylated
by CK2. The smaller degradation products of SO are not phosphorylated (asterisk+box) while the larger
proteins maintain their CK2 sites (arrows). MBP is not phosphorylated (box+arrow)
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Figure 12: To verify that CK2 is the kinase responsible for the observed phosphorylations, specific
modulators of kinase activity were used. GTP (60 µM) is a potent competitor while protamine (125
µg/mL) and spermine (500 µg/mL) activate kinase function. Curiously, heparin (1 µg/mL) has little effect
on reaction rate and poly-lysine (100 µg/mL) depletes kinase activity. It is a possibility that the two
reactions were interchanged; for absolute clarity, these experiments should be repeated.
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WT

4D

Figure 13: (A) Structural prediction of SO and a phosphomimetic (Ser to Asp substitution) SO imply
that conformational shifts may occur in the vicinity of α-6 upon CK2 phosphorylation. Specifically, a helix
toward the N-terminus of α six rotates clockwise to expose basic residues. The residues in this helix are
predicted to be DNA binding using primary sequence (BINDN+) and structural inference (DISPLAR, not
shown). (B) There are very few sequence differences among homologs (groups, arrows = nonconservative), and nearly no variation in the homeodomain Helix-3 (DNA binding) across groups. Helices
1 and 2 of the homeodomain exhibit some variation, but the movement near a helix with described
functional variability is intriguing.
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CHAPTER 3

Identification and Genetic Analysis of 14-3-3 as a Regulator of E(spl)Mδ Activity
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ABSTRACT
The C-terminal domains of Enhancer of Split Complex repressors were long
considered a non-specific linker between the body of the protein and the invariant
WRPW co-repressor binding motif. However, previous studies have revealed complex
post-translational regulation of the repressors E(spl)M8, -M5 and -M7. This involves
phosphorylation and repressor activation by CK2 and MAPK, followed by the release of
an apparent autoinhibition. In contrast to this well described mechanism, it remained
poorly understood how other E(spl) repressors, which lack the specific sequence motifs
of the aforementioned paralogs, might be regulated. Based on immunoprecipitation and
Y2H assays, 14-3-3 proteins were raised as a possible regulator of E(spl) repressors.
Here, bioinformatics was used to identify a novel, high affinity, deeply conserved 14-3-3
binding motif in E(spl)Mδ. Additionally, genetic analysis infers that this site is important
for the repressor activity mediated by E(spl)Mδ, a protein known to modulate eye
development. The bioinformatics suggest that the 14-3-3 site in E(spl)Mδ may be
targeted by protein kinases distinct from those that regulate E(spl)M8, -M5, and M7.
These findings reveal that post translational modification and cofactor regulation of the
E(spl) bHLH proteins are likely to be unique and thus non-redundant.
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INTRODUCTION
Regulation of transcription factor activity is perhaps the most important aspect of
a cell response during a developmental program. The previous chapter discussed the
potential effect of CK2 phosphorylation of E(spl)Mγ, EMC, and Sine Oculis. In addition
to kinase modification, further layers of transcription factor modulation are possible and
represent critical mechanisms in changing cellular behavior. This chapter considers the
potential for 14-3-3s and their binding to E(spl) repressors as a means to induce altered
activity.
It is well established that 14-3-3 proteins preferentially interact with
phosphorylated proteins (see Introduction). The canonical example of 14-3-3 function is
in the binding to Raf (Fu et al., 1994). In a model proposed by Tzivion et al (1998), a
14-3-3 dimer binds to phosphorylated Raf and maintains the inactive conformation.
Subsequent displacement of 14-3-3 by Ras-GTP, allows further phosphorylation and
activation of Raf, a form that is stabilized by interaction with 14-3-3 (Tzivion et al.,
1998). In this system, the role of 14-3-3 dimers is twofold: it protects specific
phosphorylated residues from phosphatases and structurally stabilizes the active
conformation.
In addition to signalling, modulation of transcription factor activity has also been
described. For example, the DNA binding activity of HNF1α is dramatically enhanced
upon 14-3-3 recruitment (Yu et al., 2013). Conversely, previous studies have elucidated
roles for 14-3-3 in nuclear exclusion and translocation of the transcription factor Yorkie
(Ren et al., 2010). Additionally, the experiments that led to an understanding of Yorkie
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regulation by 14-3-3 were performed in the Drosophila eye. This suggests that 14-3-3s
are active in this context, including the direct regulation of transcription factor function.
Interest in the interaction between 14-3-3 and E(spl) repressors is derived from a
yeast-two-hybrid (Y2H) screen that identified 14-3-3ζ as an interaction partner of the
E(spl)M8-CtD (Kim and Bidwai, unpublished). Additional evidence for 14-3-3 and E(spl)
repressor interaction can be found in the Drosophila Protein Interaction Map (DPiM), an
S2-cell based interaction network assay (Guruharsha et al., 2011). In this highthroughput study, E(spl)Mγ, Mδ, M8, M3, M5 and M7 co-immunoprecipitated at least
one 14-3-3 isoform as an interaction partner. Of the three E(spl) repressors expressed
in the MF (M8, Mγ and Mδ), E(spl)Mγ and E(spl)M8 both interacted with 14-3-3ζ and ε,
whereas E(spl)Mδ interacted with only 14-3-3ζ. However, the DPiM database did not
demonstrate whether these interactions depend on phosphorylation of E(spl) proteins.
The possibility thus arises that distinct modes of regulation are imposed on E(spl)
repressors by phosphorylation and different 14-3-3 isoforms.
Based on these preliminary findings, we sought to further investigate the
interaction between 14-3-3 and E(spl) repressors. This aspect of Notch signaling has
not been studied to date. To this end, we identified 14-3-3 binding sites in E(spl)
repressors by bioinformatics sequence analysis and performed genetic studies of
E(spl)Mδ to infer the regulatory consequences of a possible physical interaction.
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MATERIALS AND METHODS
Identification of 14-3-3 Binding Sites
The Drosophila orthologs of E(spl) repressors expressed in the morphogenetic
furrow and found to interact with 14-3-3 by the DPiM (Guruharsha et al., 2011;
Guruharsha et al., 2012) were downloaded from flybase.org and aligned using standard
settings on the MUSCLE online software. Multiple sequence alignments were visually
inspected for motifs that correspond to the high affinity binding sites described
previously by others (Yaffe et al., 1997). After resilient sequences were identified in the
Drosophila E(spl) repressors, mammalian HES proteins were downloaded from the
NCBI database and inspected for site conservation.
Genetic Analysis of E(spl)Mδ
Flies were raised on yeast-glucose medium at 24C. Specific fly stocks were obtained
from the Bloomington Stock Center at Indiana University. Stable balanced stocks were
generated and maintained using standard protocols. These lines were crossed using
virgin ♀ Nspl/Nspl; leo12BL/CyO; +/+ and ♂+/+; +/+; hH10GAL4,UAS-E(spl)Mδ/TM6B. The
recombinant stock was a generous gift from Adam T. Majot.
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RESULTS AND DISCUSSION
As mentioned above, Y2H and S2-cell based studies indicate an interaction
between 14-3-3 and E(spl) proteins. However, it was unclear if these interactions are
direct, or are mediated through accessory proteins. Consequently, the presence of well
defined interaction motifs was investigated through bioinformatics analyses.
Of primary importance was investigating the existence of interaction sites within
the E(spl) repressors. The most straightforward approach is to construct multiple
sequence alignments and identify a motif that fits the strict consensus for 14-3-3
interaction, which have been described (Yaffe et al., 1997). While discovery of Mode-1
(R-x-x-S-x-P) and Mode-2 (R-x-x-x-S-x-P) binding sites is straightforward, it is important
to note that many sites are not readily inferred based solely on primary sequence
analyses. The compiled and aligned sequences of the three morphogenetic furrow
specific repressors, E(spl)M8, -Mγ and -Mδ from the twelve Drosophila orthologs
revealed motifs in distinct domains.
14-3-3 binding motifs in E(spl)M8 and E(spl)Mγ
E(spl)M8 has a readily identifiable Mode-2 consensus within the Orange domain
(Fig. 1, left). This site is well conserved among Drosophila orthologs, but does not exist
consistently, even in closely related invertebrates (data not shown). E(spl)Mγ also
contains a conserved Mode-2 binding site, but it is located in the C-terminal domain
(Fig. 1, right). Interestingly, this site is proximal to the serine rich P-domain, a region of
multiple phosphorylations as described for E(spl)M8 (see Introduction). This raises the
possibility that direct or primed kinase targeting can form a high affinity 14-3-3 binding
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site. The position and conservation of 14-3-3 consensus sites in E(spl)M8 and E(spl)Mγ
starkly contrast the site in E(spl)Mδ.
14-3-3 binding motif in E(spl)Mδ
In E(spl)Mδ, the sequence ‘R-K-V-T-K-P’ is located in the basic domain and
closely meets the consensus for Mode-1 binding (Fig. 2A). Though residues in this
region are conserved across paralogs, this specific motif is unique to E(spl)Mδ
(compare paralogs, Fig. 3 Ch. 1). The importance of the identified site is reinforced
when sequences are aligned with vertebrate members of the Hairy and Enhancer of
Spilt homologs (HES). Specifically, HES1 and HES4 maintain a 14-3-3 site analogous
to that of E(spl)Mδ in both sequence and position (Fig. 2B). Though the motif has
changed slightly to ‘R-K-S-S-K-P,’ the spacing and chemistry of the residues have
endured through approximately 800 myr of evolution.
14-3-3 binding motifs in HES1 and HES4
Interestingly, an in frame ‘insertion’ within the 14-3-3 binding motif of the HES4
gene generates two distinct isoforms. HES4 isoform 2 maintains the site analogous to
HES1 and E(spl)Mδ (Fig. 2C). On the other hand, HES4 isoform 1 has evolved a new
site, ‘R-K-V-G-S-R-P’, which incorporates the first two basic residues of the Mode-1 site
(Figure 2A and B). The motif in HES4 isoform 1 is Mode-2 binding; these sites exhibit
similar binding affinity. Moreover, the residues near the serine are still basic, which may
be important for kinase specificity.
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14-3-3 and the E(spl)Mδ enhancement of Nspl
The existence of a high affinity consensus that is evolutionarily resilient from
E(spl)Mδ to the HES1 and HES4 repressors provided the impetus for further analysis.
Previous observations had demonstrated that the Nspl allele is marked by neural
hypotrophy in the Drosophila eye and that this phenotype is sensitive to hypermorphic
E(spl) function, namely E(spl)D (Nagel et al., 1999). Similarly, expression of E(spl)Mδ
in the morphogenetic furrow using the driver hH10GAL4 (stage 1, see Ch. 1, Fig. 4)
results in dramatic reductions in eye size (Ligoxygakis et al., 1998) and overexpression
using the driver 109.68GAL4 (stage 2/3, see Ch. 1, Fig. 4) have been compared to the
Nspl phenotype (Li and Baker, 2001). Congruently, it has been observed that E(spl)Mδ
expressed by hH10GAL4 enhances the stereotyped Nspl reduced eye phenotype
(personal communication, Adam Majot). Therefore, modulation of this enhanced
reduction of ommatidial facet counts served as a facile in vivo test for interaction
between 14-3-3 and E(spl)Mδ.
For these studies I employed the loss of function and recessive lethal allele
leo12BL. By themselves, leo12BL/+ flies display normal eyes with no perturbation (data not
shown), suggesting that half dosage of Leo is sufficient for normal eye development. In
addition, the adult eye of male flies harboring the leo12BL allele in combination with Nspl
displayed a rough and reduced eye (Fig. 3A and graph) whose severity was
indistinguishable from Nspl/Y males (data not shown). I next tested if the overexpression
phenotype of UAS-E(spl)Mδ is sensitive to this genetic background as shown in Fig.
3B,C and graph overexpression of E(spl)Mδ elicited a greater reduction in the eye field
when tested in a leo12BL/+ background. To provide a quantitative analysis of adult eye
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phenotypes, the number of facets were counted in all relevant genotypes. As shown in
the graph in Fig. 3, Nspl/Y by themselves or in combination with leo12BL/+ display ~325
facets. Overexpression of E(spl)mδ in a leo+/+ background resulted in residual eye with
~160 facets whereas expression a leo12BL/+
resulted in a reduction to ~40 facets. Statistical analysis indicates that these
differences are significant (p-value <<0.001). Thus E(spl)Mδ activity in its normal
expression domain is sensitive to 14-3-3-Leo and the exacerbation of the reduced eye
provides strong in vivo evidence that Leo normally functions to restrain E(spl)Mδ
activity.
SIGNIFICANCE
The fact that six of the seven E(spl) repressors are indicated to interact with at
least one isoform of 14-3-3 is initially a cause of concern regarding the reliability of the
DPiM results. One could speculate that the interactions are spurious contamination,
initiated by a motif common to all of the E(spl) proteins, or the basic domain of the
repressors interacts non-specifically with the acidic 14-3-3s. These ideas are countered
by the Y2H screen, which isolated 14-3-3 using only the E(spl)M8-CtD. Inspection of the
primary sequence of E(spl) repressors one can find 14-3-3 consensus motifs in most,
albeit at disparate locations with respect to protein domains. Regardless of these
complexities, the evidence presented here in describing E(spl)Mδ and its vertebrate
homologs illuminate a conserved 14-3-3 motif that appears to be resilient to change
through evolution and have functional significance during Drosophila development.
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Physical interaction between 14-3-3 and E(spl) or HES repressors would extend
their regulation into a novel direction. Given the genetic interaction between leonardo,
E(spl)mδ, and Nspl , future investigation of this interaction is warranted. This would best
be verified by in vitro assays using purified proteins and kinases that specifically target
residues in the correspondent 14-3-3 motifs. It is important to note that the serines in
the identified motif of HES are reportedly phosphorylated by PKC, thereby blocking its
ability to bind DNA (Strom et al., 1997). These findings further extend the potential for
14-3-3, because the targeting of phosphoserine motifs underlies high affinity interaction.
Because phosphorylation of the ‘R-K-S-S-K-P’ decreases DNA binding in HES1,
it would be reasonable to speculate that a similar regulation impinges upon E(spl)Mδ.
Mechanistically, the classical roles for 14-3-3 could be at play. For example, 14-3-3
binding could stabilize the inactive conformation of the repressor by preventing
dephosphorylation. Because repression of target genes occurs within the nucleus, it is
likely that subsequent consequences of E(spl)Mδ phosphorylation would involve nuclear
export and protein degradation. This directly correlates with the leo12BL mediated
exacerbation of the Nspl phenotype seen in the genetic experiments (Figure 3).
Under specific signaling conditions or developmental contexts, it is also possible
that other basophilic kinases target the residues in question. For example, PKA or PKB
are also basophilic kinases that preferentially target sequences similar to that of PKC.
This fits into the conception of Notch as having multiple and changing roles in a variety
of tissues and would allow for further functional diversification.
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One important reason for extending research with respect to 14-3-3 and
E(spl)/HES interaction can be found in emerging discussions which suggest the
potential use of chemotherapeutic agents to modify 14-3-3 function (reviewed in (Zhao
et al., 2011)). This is an extension of the observation that 14-3-3s are heavily involved in
the regulation of signaling pathways like EGFR and also are involved in regulated cell
proliferation and differentiation. To maximize the effective application of such
therapeutics, it is critical to understand all aspects of 14-3-3 functioning. This is
especially true with respect to signaling pathways known to be involved in disease
etiologies, like Notch and its terminal effectors.
Moreover, the role for E(spl)/HES in development is important, as improper
function of these repressors is associated with congenital disorders. For example,
spondylocostal dysostosis, a disease marked by skeletal malformations, is linked with
missense mutations in HES7 that cause irregularities in its oscillatory expression.
Interestingly, HES1 also exhibits an oscillatory characteristic (Hirata et al., 2002).
Hypothetically, this may be associated with signal termination by 14-3-3 dependent
nuclear export prior to degradation.
In conclusion, a conserved high affinity 14-3-3 binding site in the E(spl)/HES
repressors has been described and genetic interaction now directly implicate this
protein in Notch signaling. Though the details of this regulatory mechanism remains to
be resolved, this analysis has revealed a previously unrealized example of E(spl)/HES
regulation that is of clinical importance. Future experiments should be directed toward
characterization of the physical complex between these proteins, identification of the
relevant kinases, and investigate the relevant spatiotemporal context of the interaction.
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Figure 1: Inspection of multiple sequence alignments for the orthologs of E(spl)M8 and E(spl)Mγ reveal
14-3-3 consensus binding sites. Within the Orange domain of E(spl)M8 the sequence ‘R-V-M-A-S-T-P’ is
a conserved Mode-2 binding site. Though previous experiments (see introduction) had indicated that 143-3 binding occurs in the CtD, no strict consensus could be identified in the region. Conversely, E(spl)Mγ
harbors the sequence ‘R-D-A-Y-S-V-P’ in the CtD. This Mode-2 binding site is likewise highly conserved
in the melanogaster group. Interestingly, it is juxtaposed to the serine rich P-domain, previously shown to
be phosphorylated at multiple positions. This raises the possibility that direct or primed kinase targeting
drives 14-3-3 interaction at the relevant serine. Direct sequence similarities could not be identified in
mammalian homologs of E(spl) repressors. Drosophila melanogaster (Dmel), D. willistoni (Dwil), D.
pseudoobscura (Dpse), D. ananassae (Dana), D. yakuba (Dyak), D. sechellia (Dsec), D. simulans (Dsim),
D. erecta (Dere), D. grimshawi (Dgri), D. mojavensis (Dmoj), D. virilis (Dvir).
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Figure 2: (A) The basic domain is a highly conserved region of the E(spl) repressors (see Fig. 3, Ch. 1).
However, within the basic domain of E(spl)Mδ, a unique 14-3-3 binding motif is present. The sequence
‘R-K-V-T-K-P’ fits the Mode-1 binding consensus. This site is highly conserved not only among orthologs
of the melanogaster group, but also higher vertebrates. (B) When comparing the sequences of E(spl)Mδ
to the human homologs hHES1 and hHES4 isoform 2, it is striking that the 14-3-3 site has been
conserved. (C) hHES4 isoform 1 contains an insertion located within the 14-3-3 binding site.
Interestingly, this insertion maintains a 14-3-3 Mode-2 site of its own. Drosophila melanogaster (Dmel), D.
willistoni (Dwil), D. pseudoobscura (Dpse), D. ananassae (Dana), D. yakuba (Dyak), D. sechellia (Dsec),
D. simulans (Dsim), D. erecta (Dere), D. grimshawi (Dgri), D. mojavensis (Dmoj), D. virilis (Dvir).
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spl

Figure 3: (A)The N allele reduces facet counts in adult male flies from 750-800 to ~325. (B) Over
expression of E(spl)mδ in this background reduces facet numbers to ~175 and (C) the loss of 14-3-3
function further drives the loss of ommatidia (~75). These data indicate that E(spl)Mδ repressor activity is
negatively regulated by phosphorylation and 14-3-3 cofactor binding. The symbol ** indicates statistical
difference.
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